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CHAPTER 1
INTRODUCTION

1.1. Two Main Cellular Degradation Systems
In the microscopic environment of the cell, pathways for degradation of
proteins and organelles have evolved to ensure proper cell function and,
ultimately, the survival of the organism as a whole. The cell maintains
homeostasis by removing proteins whose activity is no longer needed, and by
degrading proteins to reutilize their amino acids during times of low nutrient
availability. The cell also uses degradation as a means of quality control (QC)
by removing misfolded proteins and damaged organelles (Mizushima, 2006).
The two main systems that govern intracellular catabolism are the ubiquitin
proteasome system (UPS) and autophagy. These degradation pathways are
involved in disease prevention, and inhibition of these pathways has been
linked to disease progression. When one degradation pathway is inhibited, the
cell will increase the activity of the other to compensate (Pandey et al., 2007;
Kaushik et al., 2008).
The UPS accounts for the majority of short-lived protein degradation
within the cell. This process is orchestrated by the attachment of the highly
conserved 76 residue polypeptide ubiquitin (Ub) to the protein substrate
through a series of three enzymatic reactions. In the first reaction the ubiquitinactivating enzyme E1 activates Ub in an ATP-dependent reaction that
generates a complex between E1 and Ub via a thiolester linkage. The activated
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Ub is then transferred from the E1 to one of several E2 ubiquitin-conjugating
proteins. Then, E2 either transfers the activated Ub to a member of the E3
ubiquitin-ligase family or a substrate to which E3 is bound. This can occur in
one of two ways. For the HECT (homologous to the E6-AP C-Terminus) E3s,
the activated Ub is transferred first to the E3 before it is subsequently
transferred to the protein substrate. In the case of E3s that belong to the Really
Interesting New Gene (RING) finger family of ligases, E3 is already bound to
the protein substrate and catalyzes the direct transfer of the E2-bound Ub to
the protein substrate. This series of reactions is repeated, and generates a
polyubiquitin chain by successively adding activated Ub molecules to an
internal lysine residue on the previous Ub molecule (for a review see Glickman
and Ciechanover, 2002).
The tagging of proteins with polyubiquitin chains is what governs the
specificity of this degradation process. Polyubiquitinated proteins are
transported to the 26S proteasome located in the cytosol or nucleus by a
mechanism that is currently unknown. The barrel shaped 26S proteasome
complex is composed of a 20S central complex and two 19S cap complexes.
The 19S segment of the proteasome binds the polyubiquitinated substrate,
removes the ubiquitin tag, and controls access to the 20S core. The catalytic
activity of the proteasome occurs in the 20S segment and the narrow 13Å
opening of the pore prevents non-specific degradation of cell proteins. This
suggests that protein substrates must be partially unfolded before entering the
20S pore (Navon and Goldberg, 2001). Proteasomal degradation of substrates

	
  

	
  

3	
  

generate peptides that are 2-24 residues long, which are further broken down
into their corresponding amino acids by endopeptidases located in the cytosol
(Saric et al., 2004). Proteins that are monoubiquitinated are directed to the
lysosome or vacuole for degradation.
Lysosomal degradation of cytosolic components is called autophagy.
There are three main forms of autophagy: macroautophagy, chaperonemediated autophagy (CMA), and microautophagy. Autophagy can either be
specific, as in the case of CMA, or non-specific, as in the case of
macroautophagy and microautophagy. Regardless, autophagy is the primary
method of clearance for long-lived proteins, protein aggregates, and even
whole organelles.
Macroautophagy involves the sequestration of cytosolic components in a
double-membrane vesicle called the autophagosome (Fig. 1). The process
begins with the formation of the phagophore near the periphery of the cell (Fig.
1) (Axe et al., 2008; Jahreiss et al., 2008).

With the help of a host of

autophagy-related proteins, the phagosome encompasses cytosolic proteins
and organelles (for a review see Xie and Klionsky, 2007). When the two ends
of the phagosome meet, it is defined as an autophagosome. The nascent
autophagosome moves towards the microtubule-organizing center (MTOC),
fusing with late endosomes to form hybrid intermediates called amphisomes
(Jahreiss et al., 2008).

Autophagy is complete once the mature

autophagosome fuses with the lysosome to form an autolysosome (Furuno et
al., 1982). Here, the acidic environment and resident hydrolases break down
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the autophagosome constituents, creating nutrients that are then recycled back
into the cell.
Microautophagy

occurs

when

the

lysosomal

membrane

forms

invaginations or tubulations that “pinch off” from the membrane into the lumen
of the lysosome, sequestering regions of the cytosol (Fig. 1) (Muller et al.,
2000). This results in the direct uptake of cytosolic components adjacent to the
lysosome, including cellular	
  organelles that are no longer needed (Ahlberg and
Glaumann, 1985; Sakai et al., 1998). Recently, studies have indicated that this
process may specifically sequester peroxisomes, mitochondria and even
portions of the nucleus (Yen and Klionsky, 2008). For example, in yeast, after
treatment to induce peroxisome proliferation, excess peroxisomes are removed
via microautophagy (Bellu and Kiel, 2003).
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Figure 1: Selective and non-selective autophagy. Here, a schematic depicts
various types of selective and non-selective autophagy, where selectivity is
determined by the specificity of the cargo. Some features depicted in this
diagram are not included in the above discussion. Adapted from Yen and
Klionsky, Physiology, 2008.
Chaperone mediated autophagy (CMA) differs from all other types of
autophagy because it allows for the degradation of cytosolic proteins on a
molecule-by-molecule basis (Fig. 1) (Dunn, 1994). In this process, proteins
containing the pentapeptide recognition motif KFERQ are recognized by the
cytosolic chaperone heat shock cognate protein 70 kDa (hsc70) (Dice, 1990;
Cuervo et al., 2000). This interaction targets the substrate-chaperone complex
to the lysosome which binds to lysosome associated membrane protein type 2A
(LAMP-2A) (Agarraberes and Dice, 2001). After unfolding, the substrate
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translocates into the lysosome with the help of the luminal chaperone, lyshsc70, where it is then rapidly degraded by resident hydrolases (Salvador et al.,
2000).
Autophagy, plays a pro-survival role within the cell and allows the cell to
restore nutrient homeostasis and to clear misfolded proteins and damaged
organelles that would otherwise be damaging to the cell. Autophagy is induced
in response to nutritional deprivation (Mortimore et al., 1983; de Waal et al.,
1986; Komatsu et al., 2005), hypoxic conditions (Adhami et al., 2006), during
embryogenesis (Tsukamoto et al., 2008), and is responsible for the turnover of
long-lived proteins (Ahlberg and Glaumann, 1985), damaged organelles
(Mathew et al., 2009), and misfolded proteins (Ishida et al., 2009). Drug
treatment can also cause an autophagic response due to drug-induced cellular
stress. For example, treatment with rapamycin directly interacts with
mammalian target of rapamycin (mTOR) and prevents its negative regulation of
autophagy, even in nutrient-rich conditions (Blommaart et al., 1995; Kim et al.,
2002).
Autophagy is also recognized for its pro-death role within the cell. In fact,
it is recognized as Type II programmed cell death (Kroemer and Jaattela,
2005). Autophagic cell death can occur under conditions where apoptosis is
inhibited and is denoted by the excessive presence of autophagosomes within
the dying cell (Shimizu et al., 2004; Yu et al., 2004). In dying cells in which
apoptosis is still functional, enhanced levels of autophagy can precede
apoptosis and emerging evidence suggests that induction of autophagy may
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even result in cell death by apoptosis (Saiki et al., 2011; Cui et al., 2007). This
evidence is suggestive of the close relationship between these two death
pathways (for a review see Eisenberg-Lerner et al., 2009).
1.2. Macroautophagy
The scope of work presented here focuses mainly on macroautophagy
(hereafter refered to as autophagy). The main identifier of macroautophagy is
the autophagosome. Sam L. Clark first observed the autophagosome in 1957
while examining the kidneys of newborn mice and rats by electron microscopy
(Clark, 1957). He described them as “vacuoles that have accumulated a high
concentration of amorphous material”. Since then the autophagosome has
been studied extensively in yeast and various mammalian systems. The main
morphological identifier of the autophagosome is its distinctive double
membrane first reported by Ashford and Porter (1962). The autophagosome is
also recognized by its initial lack of acid phosphatase and aryl sulfatase
activities (Arstila and Trump, 1968; Dunn, 1990).
Upon initiation of autophagy, an isolation membrane or phagophore
forms within the cytosol and expands to encompass cytoplasmic constituents
(Fig. 2) (Jahreiss et al., 2008). The origin of the phagophore has yet to be
defined, but there is evidence that the endoplasmic reticulum (ER) may provide
fatty acids for autophagosome membrane formation (Dunn, 1990; Axe et al.,
2008). The two ends of the phagophore continue to expand until they meet to
form a fully enclosed vacuole called the autophagosome. At this moment the
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autophagosome contains cellular constituents that have not been degraded
and, therefore, is termed a nascent autophagosome. Through various electron
microscopy studies, autophagosomes have been shown to merge with
endocytic compartments (early and late endosomes) shortly after formation
(Liou et al., 1997; Gordon and Seglen, 1988).

Gordon and Seglen (1988)

coined the term “amphisome” to describe the vacuole that results from the
fusion of an autophagosome and endosome (Fig. 2). These fusion events result
in the maturation of the autophagosome which is characterized by the
acquisition of lysosomal membrane proteins, hydrolases and increased acidity
(Liou et al., 1997; Berg et al., 1998).
The formation of the autophagosome involves a series of autophagyrelated proteins (Atg). These proteins were first identified and named in yeast.
With the subsequent discovery of mammalian orthologs, the mammalian
autophagy protein nomenclature became a hybrid of yeast and new
mammalian-specific names (see Table 1 for a list of common autophagy
proteins) (Yang and Klionsky, 2009).
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Table 1: Autophagy-related protein yeast and mammalian nomenclature

Two ubiquitin-like conjugation systems lead to the expansion and
closure of the phagophore resulting in an autophagosome (Mizushima et al.,
1998; Kabeya et al., 2000). In the first system, Atg12 is covalently conjugated
to Atg5 through the actions of Atg7 and Atg10, which represent E1 and E2-like
enzymes, respectively. The Atg5-Atg12 conjugate associates with Atg16L to
form the Atg12-Atg5-Atg16L complex (Mizushima et al., 2002). The Atg12Atg5-Atg16L complex associates primarily with the outer side of the growing
phagophore and dissociates once the autophagosome is fully formed.
In the second ubiquitin-like system, Atg4, Atg3 and Atg7 conjugate LC3
(microtubule-associated protein light chain 3) to phosphatidylethanolamine
(PE). Before LC3 has the PE conjugated to it, the protein is located in the
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cytosol and is referred to as LC3-I (Kabeya et al., 2000). The lipidated form of
LC3 rapidly associates with the autophagosome membrane, and at that
moment is referred to as LC3-II. Recent studies show that LC3 regulates
autophagosome size during autophagosome formation (Xie et al., 2008). While
Atg4 cleaves LC3-II on the outer membrane of the autophagosome, LC3-II on
the inner membrane remains intact until it is degraded in the autolysosome,
along with the autophagosome cargo. The distinct association of LC3-II with the
autophagosome membrane has made it an important tool in the study and
identification of autophagy and is widely used as a marker for autophagy
(Tanida et al., 2005).
Only recently has information regarding the final stage of the autophagy
process, autophagosome–lysosome fusion and degradation, been revealed.
Autophagosomes move toward the microtubule organizing center (mTOC) via
microtubule tracks and dynein motors (Kochl et al., 2006). The final destination
of the autophagosome is the lysosome where the outer membrane fuses with
the lysosome forming an autolysosome (Fig. 2) (Jahreiss et al., 2008; Yu et al.,
2010). In yeast, autophagosome and vacuole fusion has been extensively
studied showing the involvement of similar fusion machinery used in
endosome-endosome and endosome-lysosome fusion, the Rab-SNARE
system (Collins et al., 2005; Rohde et al., 2003). Autophagosome-lysosome
fusion in the mammalian system still requires	
   further analysis, but Rab 7 has
been shown to be involved in the process (Jager et al., 2004; Yu et al., 2010).
Upon fusion with the lysosome, the contents of the autophagosome are
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degraded by resident hydrolases, which allows the corresponding amino acids
to be recycled back into the cell (Xie and Klionsky, 2007).
In 2010, Yu et al. (2010) described lysosome reformation following
autolysosome formation. They showed that normal rat kidney cells undergoing
starvation-induced autophagy displayed tubular structures emerging from the
autolysosome following 8 h of starvation. These structures were positive for the
lysosomal surface protein LAMP1, but lacked an acidic environment like that of
lysosomes and autolysosomes.

Within 16 h of starvation, these tubules

became acidic and acquired degradative capabilities indicating the formation of
new, fully active lysosomes.	
  	
  

	
  
Figure 2: Autophagosome formation and maturation. Autophagosome
formation begins with the phagophore. Recent studies performed in yeast
suggest that the phagophore may partially originate from portions of the ER.
The two ends of the phagophore elongate, engulfing cytosolic constituents,
ultimately meeting to form a complete autophagosome. The autophagosome
matures by fusing with early and late endosomes to form amphisomes. Finally,
the mature autophagosome/amphisome fuses with the lysosome where its
cargo is degraded by resident lysosomal hydrolases. Adapted from Eskelinen
and Saftig, Biochim Biophys Acta, 2009.
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1.3. Induction of autophagy
Multiple pathways are responsible for triggering the induction of
autophagy. These pathways can be categorized into either the “canonical
pathway” and the “non-canonical pathway”. The distinction between the two
pathways is defined by the requirement for Beclin-1. Beclin-1 (the mammalian
orthologue of yeast Atg6) and the class III phosphatidylinositol 3 kinase,
hVps34, are required for the formation of the phagophore in the canonical
pathway. Whereas, in the non-canonical pathway, phagophore formation
occurs independently of Beclin-1 and hVps34, but does appear to be
dependent on Atg7 (Fig. 3) (Zhu et al., 2007; Yano et al., 2007, Scarlatti et al.,
2008; Wong et al., 2010). This distinction was demonstrated in a recent study
by Scarlatti et al. (2008), where breast cancer cells treated with resveratrol
underwent cell death through multiple pathways including Beclin-1 independent
autophagy. Knockdown of the ATG7 gene impaired autophagy, while disabling
BECN1 (the gene that encodes for Beclin-1) or hVPS34 (the gene that encodes
for hVps34) gene expression had no effect on resveratrol induced autophagic
cell death.
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Figure 3: Canonical and non-canonical autophagy. Phagophore formation in
canonical autophagy requires the Beclin-1/hVps34 complex along with Atg9,
the Atg1 complex and WIPI-1 (Atg18 ortholog). In non-canonical autophagy,
phagophore formation occurs independently of Beclin-1/hVps34. Both utilize
the two ubiquitin-like systems that include Atg12-Atg5-Atg16L and LC3-II. To
date, canonical autophagy is involved in cell survival, caspase-dependent and –
independent cell death, while non-canonical autophagy is only associated with
caspase-independent cell death. Adapted from Scarlatti et al., Cell Death and
Differentiation, 2009.
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The canonical pathway can be further divided into two additional

pathways, the mTOR-dependent and –independent pathways.

The mTOR-

dependent pathway is negatively regulated by mTOR and is modulated by
nutrient status, growth factor exposure and stress signals (Scott et al., 2004;
Vander Haar et al., 2007; Sofer et al., 2005). mTOR actually represents two
individual complexes: mTORC1, which consists of mTOR, raptor (regulatoryassociated protein of mTOR) and GβL (G-protein β-subunit like protein) and
mTORC2, which consists of mTOR, rictor (rapamycin-insensitive companion of
mTOR) and GβL (Fig. 4) (Li et al., 2007). When autophagy is induced, either
by nutrient deprivation or by rapamycin treatment, mTOR kinase activity is
inhibited, causing the partial dephosphorylation of Atg13 and ULK1/2 (Jung et
al., 2009). This allows the serine/threonine kinases ULK1 and ULK2 (unc-51like kinase proteins 1 and 2) to phosphorylate FIP200 (focal adhesion kinase
family-interacting protein of 200 kDa) resulting in the induction of autophagy
(Hara et al., 2008).	
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Figure 4: The mTOR pathway. mTOR is regulated through
phosphatidylinositol 3-kinase (PI3K) in response to insulin (or growth factors)
binding to the insulin receptor. Activated insulin receptor substrates (IRS)
activate PI3K, which recruit phosphoinositide-dependent kinase 1 (PDK1) and
Akt to the cell membrane. Akt is then phosphorylated and activated, which
phosphorylates tuberous sclerosis complex 1/2 resulting in its inactivation. This
allows Rheb to be activated, which in-turn activates mTOR. Association of
Raptor and GβL with mTOR forms the mTORC1 complex and stimulates its
kinase activity leading to the activation of downstream effectors S6K and
elF4G. Under starvation conditions or rapamycin-treatment, the mTORC1
complex dissociates resulting in the induction of autophagy. A second mTOR
complex, mTORC2, is assocated with Rictor and GβL and can directly
phosphorylate and activate Akt. The TSC 1/2 complex is also regulated by
AMPK in response to changes in energy status. AMPK can directly
phosphorylate TSC2 and inhibit mTORC1. Adapted from Hartford and Ratain,
Clin Pharmacol Ther, 2007.
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mTOR-independent autophagy can be initiated through two different

signaling pathways that ultimately converge to influence myoinositol-1,4,5triphosphate (IP3) levels, thereby activating or inhibiting autophagy (Williams et
al., 2008; Sarkar et al., 2005; Criollo et al., 2007). In the first arm of the mTORindependent pathway, otherwise known as the cAMP-Epac-PLCε-IP3 pathway,
increased adenyl cyclase activity increases cAMP levels. This activates the
guanine nucleotide exchange factor Epac, which then activates Rap2B (a small
G-protein). When Rap2B is activated, it results in the activation of
phospholipase C (PLC-ε), whose action is to hydrolize phosphatidylinositol-4,5bisphosphate to form IP3 and diacylglycerol and in turn inhibits autophagy
(Williams et al., 2008). The second arm of the pathway involves the Ca2+calpain-Gs pathway, which was initially described by Gordon et al. in 1993
α

when he realized that agents that increased intracellular Ca2+ also inhibited
autophagy. In this pathway, an increase in intracellular Ca2+ activates calpains
(Ca2+-dependent cysteine proteases), which results in the activation of Gs . Gs
α

α

then increases adenyl cyclase activity, which then elevates cAMP levels.
At this step the two arms of the mTOR-independent pathways converge.
Inhibiting either arm of the pathway results in a decrease in IP3 production and
induces mTOR-independent autophagy. Studies performed by Williams et al.
(2008) showed that verapamil, amiodarone, and nitrendipine induce autophagy
by preventing the influx of Ca2+ by inhibiting L-type Ca2+ channels in the plasma
membrane, thereby reducing intracellular Ca2+. Agents that inhibit calpain,
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adenyl cyclase, or reduce	
   inositol and IP3 levels can also induce autophagy
through the mTOR-independent pathway.	
  
Recent studies indicate that inhibition of both the mTOR-dependent and
-independent pathways produce additive effects in autophagy. For instance,
treatment with lithium, which acts through the mTOR-independent pathway,
and rapamycin, which acts through the mTOR-dependent pathway, led to a
greater degree of clearance of Huntington’s disease (HD) aggregates during
combined treatments, as compared to separate treatments (Berger et al., 2006;
Sarkar et al., 2005; Sarkar et al., 2008). The same effect is seen when
combining trehalose, a non-reducing disaccharide that induces autophagy in a
mTOR-independent manner, with rapamycin (Sarkar et al., 2007). This effect
was also observed when applied in vivo using a HD Drosophila model. This
approach displays a unique utilization of different autophagy pathways that
could be a potential strategy for treatment of various neurodegenerative
disorders.
1.4. Regulation of Autophagy
Autophagy is a highly regulated process that is governed by
developmental and nutritional signals, and is regulated at the cytoplasmic and
nuclear level. The most well-known cytoplasmic autophagy regulators are the
mTOR complexes, mTORC1 and mTORC2.

The serine/threonine kinase

activity of mTOR is highly conserved (Takahashi et al., 2000). In normal cellular
conditions, mTOR kinase activity is suppressed by the tuberous sclerosis
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complex (TSC) and forms the mTORC1 complex with Raptor, GβL or hVps34
(Kim et al., 2003; Oshiro et al., 2004). This allows downstream effectors to
promote cell growth, transcription, translation and cytoskeletal organization
(Inoki et al., 2002). mTOR activity inhibits the activity of the serine/threonine
kinases

ULK1

and

ULK2

(the

mammalian

phosphorylation (Jung et al, 2009).

equivalent

to

Atg1)

by

Unlike the yeast Atg1:Atg13:Atg17

complex, ULKs remain associated to Atg13 and FIP200 (the mammalian
equivalent

to

Atg17)

regardless

of

nutrient

status

forming

the

ULK:Atg13:FIP200 complex (Jung et al., 2009). Inhibition of mTOR prevents
the proper assembly of the mTORC1 complex allowing for activation of the
ULKs, which in-turn phosphorylate Atg13 and FIP200 and initiate the formation
of the phagophore (Jung et al, 2009). There is also evidence that mTORC1
activity is spatially regulated by Rag GTPases (Ras-related small GTPases)
(Sancak et al., 2008).

Rag GTPases activate mTORC1 by promoting its

redistribution to specific subcellular compartments that contain the mTORC1
activator Rheb (Ras homolog enriched in brain).
The Beclin-1:hVps34:hVps15 trimer is another example of regulation of
autophagy by cytosolic components. This complex interacts with various
partners to regulate the formation and elongation of the autophagosome
(Itakura et al., 2008). The direct binding with Beclin-1 controls these actions.
The anti-apoptotic proteins Bcl-2 or Bcl-XL interact with Beclin-1’s BH3 domain
via a BH3 receptor domain (Maiuri et al., 2007). The Bcl-2 or Bcl-XL interaction
with Beclin-1 inhibits autophagy, and processes that interrupt this interaction
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promote autophagy (Boya and Kroemer, 2009). One method that mediates the
dissociation of Beclin-1 from Bcl-2 is phosphorylation of Bcl-2. For example, in
response to starvation or ceramide treatment, c-Jun N-terminal	
   kinase 1 (JNK1) will phosphorylate Bcl-2, triggering it to release Beclin-1, which in turn
promotes autophagy (Pattingre et al., 2009). Beclin-1 dissociation can also be
achieved by competitive displacement of Bcl-2/Bcl-XL by other BH3-containing
proteins, such as Bad, or the BH3-only proteins BNIP3 (Bcl-2/adenovirus E1B
19-kDa interacting protein 3) and BNIP3L (Bcl-2/adenovirus E1B 19-kDa
interacting protein 3 like) (Maiuri et al., 2007; Bellot et al., 2009).
Nuclear regulation of autophagy includes the expression of a number of
nuclear factors that mediate the expression of various autophagy genes in
response to stimuli that promote autophagy. One example of this can be seen
in human cancer cell lines, where an increase in sphingolipid ceramides leads
to increased gene expression of Beclin-1 through the activation of JNK (Li et
al., 2009). This is achieved through phosphorylation of c-Jun, which in turn
increases the expression of BECN1 and results in the induction of autophagy.
The E2F1 transcription factor is another example of nuclear regulation
and has been shown to induce autophagy by directly up-regulating the
expression of autophagy genes Map1lc3 (the gene that encodes LC3), Ulk1,
Dram (the gene that encodes for DRAM (damage-regulated autophagy
modulator), and indirectly up-regulates Atg5 (Polager et al., 2008). Under
hypoxic conditions the transcription factor HIF-1 (Hypoxia-inducible factor-1)
induces the expression of BNIP3 and BNIP3L and results in the induction of
	
  

	
  

20	
  

autophagy (Bellot et al., 2009). In the absence of growth factors, FoxO
(Forkhead box ‘Other’) proteins translocate to the nucleus and induce the
expression of multiple autophagy genes, including Map1lc3, Atg12, BECN1,
Atg4b, Ulk1, Bnip3/Bnip3l, and Pik3c3 (the gene that encodes for hVps34)
(Mammucari et al., 2007).
p53 appears to both inhibit and induce autophagy based on its location
within the cell. When wild-type p53 translocates to the nucleus in response to
cellular stress it transcriptionally activates Dram. Crighton et al. (2006)
demonstrated that p53 induced autophagy in a DRAM-dependent manner.
Alternatively, mutant p53 suppresses autophagy when it is located in the
cytosol (Morselli et al., 2008). This contradictory role of p53-regulated
autophagy is an example of p53’s complex role within autophagy.
1.5. The Role of the Cytoskeleton in Autophagy
The cellular cytoskeleton is composed of elements belonging to three
main families of fibrous polymers: actin, microtubules (MT), and intermediate
filaments (IF).

Each is located throughout the cytoplasm and performs

specialized functions. They add structure and strength to the cell (Fuchs and
Cleveland, 1998), allow for mobility (Theriot et al., 1992), allow for intracellular
compartmentalization and trafficking (Lippincott-Schwartz et al., 1995), and
even modulate cell pigmentation (Schliwa et al., 1979). Very little is known
about the roles of the cytoskeleton in autophagy, but recent studies are
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beginning to reveal the importance of these elements in specific aspects of the
autophagic process.
Actin: Actin monomers assemble to form filaments in a highly dynamic
process. Some actin filaments (F-actin) are highly dynamic, while others are
very stable (McGrath et al., 2000).

Actin filaments act as a structural scaffold

for the cell and drive membrane protrusions for cell movement (McGrath et al.,
2000). Currently, the role of F-actin in autophagy has been well studied in
yeast, while very little is known about its function in mammalian autophagy. Yet,
in both yeast and mammalian systems the role of F-actin appears to be
associated with QC autophagy.	
   	
   In yeast, intact F-actin was necessary for
selective uptake of peroxisomes (Reggiori et al., 2005) and endoplasmic
reticulum (ER) fragments during rapamycin-induced autophagy (Hamasaki et
al., 2005).

In mouse embryonic fibroblasts (MEFs), Lee et al. (2010)

demonstrated that HDAC6 (histone deacetylase 6) and F-actin were critical for
QC autophagy, but not necessary for starvation-induced autophagy. This latter
study also suggested that F-actin is necessary for efficient autophagosomelysosome fusion during QC autophagy.
Microtubules: α- and β-tubulin monomers heterodimerize and self-assemble
into polarized tube-like structures (Summers and Kirschner, 1979). α-tubulins
are termed the minus end (the shrinking end) and are oriented to face the
center of the cell. β-tubulins are termed the plus end (growing end) and extend
toward the surface of the cell (for a review see Desai and Mitchison, 1997). MT
assembly and disassembly occurs at both ends, however the plus end is the
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more dynamic end, and polymerizes/depolymerizes much faster than the minus
end (Margolis and Wilson, 1978). The ATP-dependent motor protein families,
kinesin and dynein, move cargo up and down the surface of microtubules (MT)
in a step-wise manner, with kinesins moving cargo towards the plus end of the
microtubules and dyneins moving cargo toward the minus end (Hirakawa et al.,
2000).
MTs are a crucial cellular component and are involved in cell division
(Shaw et al., 2000), differentiation, cell shape (Rodionov et al., 1993),
chromosome segregation (Lacefield et al., 2009), positioning of organelles
(Murray et al., 2000; Bananis et al., 2004) and serve as a track for intracellular
movements (Schnapp et al., 1985). In autophagy, MTs contribute to the fusion
of autophagosomes and lysosomes (Webb et al., 2004). Autophagosomes
associate directly with dynein proteins that move them in the direction of the
MTOC and closer to the late endosomes and lysosomes (Kimura et al., 2008).
Recently, MTs were found to be required for starvation induced autophagy
(Fass et al., 2006).

Geeraert et al. (2010) showed that nutritional stress

triggered hyperacetylation on both stable and labile MTs as well as the
recruitment of dynein and kinesin-1 allowing for the organized trafficking of
autophagosomes. It was originally thought that MT destabilization by
nocodazole or vinblastine treatment inhibited autophagosome-lysosome fusion,
but recent studies have shown that MT disruption only causes a delay in fusion
(Fass et al., 2006; Jahreiss et al., 2008).
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Intermediate Filaments (IF): This family of proteins is composed of multiple
types of polymers, most of which are located in the cytoplasm except for one
type, the lamins, which are nuclear. There are six major classes of IFs, each
with its own specialization. Type V IFs, lamins, are located in the nucleus and
provide structure to the nucleus (Hozak et al., 1995). Type I and type II IFs
encompass more than 20 keratin proteins. They provide structure to epithelial
cells and are the structural component of hair and nails (Sun et al., 1979; Roh
et al., 2004).
The most widely distributed IF is the type III IF, vimentin, which can be
found in fibroblasts, leukocytes, blood vessel endothelial cells, mesenchymal
cells and is expressed transiently within many cells during early stages of
development (Lamb et al, 1989; Brown et al., 2001). Vimentin provides cell
structure, strength, and intracellular organization (Brown et al., 2001; Milner et
al., 2000). Vimentin can also be found in most types of cultured and tumor cells
(Dellagi et al., 1987; Franke et al., 1981). Vimentin is the key marker of
metastatic cancer cells that have undergone	
   the epithelial-mesenchymal
transition. Vimentin expression levels in metastatic cells appears to correlate
with the invasive potential of prostate and breast cancer cells (Thomas et al.,
1999; Lang et al., 2002).
The signature element of IFs is a centrally located domain of a ~310
amino acid sequence that features heptad repeats. In these repeats, every
seventh residue is hydrophobic. That pattern facilitates the formation of αhelical coiled-coil parallel heterodimers. Each monomer is flanked by a non	
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helical N-terminal and an α-helical C-termini side-arm domain (Geisler et al.,
1983).

This central domain allows for the formation of parallel coiled-coil

polymers.
Filament formation begins by first arranging monomers into parallel, inregister, α-helical, coiled-coil dimers mediated by the long-range heptad
repeats (for a review see Qin et al., 2009). Dimers then associate in a head-toside-arm fashion forming anti-parallel, apolar tetramers. Tetramers pair to form
protofilaments and eight protofilaments arrange to form the final 10 nm filament.
The final step involves compaction via lateral rearrangements without the loss
of filament mass or length.
Depending on their exposure, N-terminal head groups and C-terminal
side-arms mediate interactions with other filaments and cellular proteins. Posttranslational modifications, such as phosphorylation, also occur at the N- or Ctermini, which regulates structure, organization and function (Eriksson et al.,
2004). The non-helical N- and C-termini vary extensively between different IFs,
and play major roles in their specialized function and regulation (Herrmann and
Aebi, 2004).
Surprisingly, little is known about the role of IFs in autophagy. This can
be attributed to a lack of known selective IF-disrupting agents. The few studies
that have been performed hint at a role for IF in autophagy. In 1987, Doherty et
al. reported that microinjected glycolytic enzymes appear to form aggregates
that localize to cell fractions rich in vimentin. These aggregates were then
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degraded slowly by a lysosomal mechanism, most likely by autophagy, as
determined by lysosomal inhibitors. My project ultimately identified a role for
vimentin in autophagy. Hence, further discussion of this IF is merited.
1.6. Vimentin
In most vertebrate cells, vimentin is a highly dynamic cytoplasmic protein
that assembles from monomers into filaments, which extend from the MTOC to
the plasma membrane (Hermann and Aebi, 2004). Vimentin filament assembly
and disassembly is a highly dynamic process regulated by the phosphorylation
status of serine and threonine residues located at the N- and C-terminals
(Eriksson et al., 2004; Fuchs and Weber, 1994). Phosphorylation of vimentin by
protein kinase C (PKC), protein kinase A (PKA) and a host of other kinases,
drives disassembly of the filament structure and dephosphorylation of vimentin
monomers drives filament assembly (Holen et al., 1992; Ivaska et al., 2005).
The vimentin network integrates and organizes the cytoplasm, providing
mechanical integrity necessary for proper cell function.

One major role of

vimentin is to provide protection against mechanical stress. Vimentin-deficient
cells are less stiff and are more easily ruptured (Eckes et al., 1998). Another
role of vimentin is vesicle transport, including the arrangement and organization
of lysosomes. Vimentin-null fibroblasts concentrate lysosomes in the
perinuclear region of the cell, and exhibit an inability to properly acidify
lysosomes (Styers et al., 2004). This is possibly due to the interaction between
vimentin and AP-3, an adaptor protein crucial for intracellular sorting of
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lysosomes and lysosome-related organelles, such as melanosomes and
synaptic vesicles (Peden et al., 2004; Chapuy et al., 2008).

Additionally,

vimentin’s association with SNAP-23 and SNAP-25, and its ability to bind
negatively charged phospholipids through its non-helical head domain may also
play a role in vesicle transport and fusion (Faigle et al., 2000 and HorkovicsKovats and Traub, 1990, respectively).
Vimentin interacts closely with actin and MT, and even utilizes MT
associated motor proteins, dynein and kinesin, to aid in its own motility,
assembly and maintenance (Prahlad et al., 1998; Esue et al., 2006).
Destabilization of the MT network by nocodazole treatment, results in the
relocalization of vimentin filaments to a perinuclear location, demonstrating the
inter-relationship of the two cytoskeletal components in cellular organization
(Gurland et al., 1995). In vimentin-deficient fibroblasts, fewer actin bundles
were detected within the cell, but the bundles appeared to be thicker and focal
adhesions appeared to be more sparse, and larger in size than their wild-type
counterparts (Eckes et al., 1998).
Abnormal accumulation of IFs occur in a number of human
neurodegenerative disorders including amyotrophic lateral sclerosis (ALS),
dementia with Lewy bodies, and Parkinson disease (Al-Chalabi and Miller,
2003). Specifically, vimentin immunoreactivity was found to be intensely
positive in affected brain tissues of Alzheimer’s disease (AD), Niemann Pick
type C disease (NPC), ALS and multiple sclerosis (MS) (Yamada et al., 1992,
Morcos et al., 2003). Increased vimentin staining in atrophic muscle fibers are
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found in biopsies of Charcot-Marie-Tooth (CMT) patients, a hereditary motor
and sensory neuropathy disorder (Ericson et al., 1998). Vimentin also appears
to play an important role in additional tissue specific diseases, such as cataract
formation in humans and mice (Muller et al., 2009).
1.7. Diseases Associated with Autophagic Stress
Increased autophagosome content does not necessarily correlate with
increased autophagic activity, but it is the morphological indicator of autophagic
stress. Autophagic stress is defined as a sustained imbalance in which
autophagosome formation exceeds autophagosome degradation (Chu, 2006).
This imbalance can occur due to a number of reasons including (1)
autophagosome synthesis overwhelming rates of autophagosome degradation,
(2) an inability to deliver the autophagosome to the lysosome for degradation,
(3) inhibition of fusion between the autophagosome and lysosome, or (4) the
inability of the lysosome to degrade the autophagosome and its contents.
Similar to oxidative stress, it is conceivable that different cell types are more
susceptible to autophagic stress than others.
Increased numbers of autophagosomes and autolysosomes are often a
common feature in diseased or dying neurons (Clarke, 1990). Autophagosome
accumulation is associated with a number of neurodegenerative disease states
including ALS, AD, and HD. Both ALS and HD are linked to functional
mutations in the endosomal protein, ESCRT (Endosomal Sorting Complex
Required for Transport), resulting in the inhibition of autolysosome formation
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(Filimonenko et al., 2007). In the brain of AD patients, massive accumulation of
autophagosomes and autolysosomes suggest that autophagic stress is caused
by impaired autophagosome maturation and defective degradation within
autolysosomes (Boland et al., 2008). Niemann Pick Type C (NPC),
Mucolipidosis IV, and Dannon diseases are all examples of lysosomal storage
diseases (LSD) that exhibit autophagic stress (Pacheco et al., 2007;
Vergarajauregui and Puertollano, 2008; and Yang and Vatta, 2007,
respectively). Interestingly, these LSDs and a number of other diseases are
also associated with intracellular accumulation of lysosomal cholesterol.
1.8. Lysosomal Storage Diseases: NPC
Lysosomal storage disease (LSD) is the term used to describe over 40
different pathologies resulting from the defective activity of lysosomal proteins
which stem from a variety of genetic mutations (for a review see Futerman and
van Meer, 2004). LSDs are characterized by the intra-lysosomal accumulation
of non-metabolized substrates. As discussed above, failure to properly degrade
cellular constituents is deleterious to the cell. In LSDs, this is the primary cause
of diseases’ pathology. LSD classification is largely based on the substrate that
accumulates within the lysosome. For example, the Niemann Pick diseases
accumulate large amounts of non-esterified cholesterol, sphingolipids and other
sterols within the late endosome and lysosome and are therefore referred to as
a lipid storage disease (Mukherjee and Maxfield, 2004).
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Niemann Pick diseases encompass a group of clinically similar

autosomal recessive lipid storage disorders based on the pioneering work of
Albert Niemann and Ludwig Pick in the 1920’s. This disease was later divided
into three subtypes, A, B	
  and C, based on variability in the age of onset, clinical
expression and level of sphingomyelin storage in tissues (Crocker and Farber,
1958). Niemann Pick disease type A (NPA) and Niemann Pick disease type B
(NPB) are both characterized by massive visceral and cerebral sphingomyelin
storage due to a deficiency in the enzyme sphingomyelinase (Brady et al.,
1966). NPA exhibits an acute onset with early central nervous system (CNS)
deterioration, while NPB is marked by a chronic onset and sparing of the
nervous system (McGovern et al., 2006; McGovern et al., 2008). NPC is
characterized by lysosomal/late endosomal sequestration of endocytosed nonesterified cholesterol/sterols, alterations in intracellular sterol trafficking and,
unlike NPA and NPB, sphingomyelinase is functional (Koh and Cheung, 2006).
The incidence of NPC is estimated to be 0.82 per 100,000 births
diagnosed within the 2000-2009 period

(Vanier, 2010).

NPC is generally

recognized as a childhood disease, with onset usually recognized during early
infancy, but in some extraordinary cases, not identified until adulthood. It has
been refered to as “childhood Alzheimer’s” due to the main symptom of
progressive neurodegeneration. Neural pathogenesis results in meganuerite
formation,

neurofibrillary

tangles,

neuroinflammation

dystrophy (Walkley and Suzuki, 2004).

and

neuroaxonal

Neuronal cell death occurs as the

disease progresses in certain regions of the brain, mainly in Purkinje cells of
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the cerebellum. Physiological symptoms consist of cerebellar ataxia, dysarthria,
dysphagia and progressive dementia (Alvarez et al., 2008). Currently, there is
no known cure for NPC, and symptoms are managed by available drug
therapies.
The impairment of processing and utilization of endocytosed cholesterol
plays a key role in NPC pathogenesis. Lipid accumulation in NPC cells may
also result in the modulation of the trafficking of other late endosomal proteins.
Previous studies report that lipid accumulation within late endosomes are
associated with defects in glucoceramide hydrolysis, as well as trafficking
alterations of Rab 9 proteins and manose-6-phosphate receptors (Ganley and
Pfeffer, 2006, Walter et al., 2009).
Non-esterified

cholesterol/sterol

accumulation

within

late

endosomes/lysosomes is the hallmark of NPC disease. In NPC patients nonesterified

cholesterol,

gangliosphingolipids,

sphingosine,

sphingomyelin,

bis(monoacylglycerol) phosphate, glycolipids, and free sphingosine and
sphinganine accumulate in the brain, liver and spleen of NPC patients and
murine models (te Vruchte et al, 2004; Walkley and Vanier, 2009).

Although

an overall decrease in brain non-esterified cholesterol content occurs as NPC
mice age, that is due to selective neural cell death and demyelination	
   (Beltroy
et al., 2005; Liao et al., 2007).
NPC is caused by mutations in either of the npc1 or npc2 genes
(Carstea et al., 1997).

	
  

The npc1 gene encodes a large membrane
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glycoprotein, NPC1, which localizes to the late endosome (Scott et al., 2004).
The npc2 gene encodes a small soluble protein (NPC2) that is found in the
lysosome and binds to cholesterol with a high affinity (Friedland et al., 2003).
Approximately 95% of NPC patients carry a mutation in the npc1 gene, while
the remaining 5% contain a mutation in the npc2 gene (Vanier et al., 1996).
Both proteins contain a putative sterol-sensing domain whose role is still
unclear, but is necessary for proper protein function (Friedland et al., 2003;
Millard et al., 2005). In patient and animal studies, both NPC1 and NPC2
appear necessary for proper cholesterol egress from the lysosome (Neufeld et
al., 1999; Infante et al., 2008).

NPC1, NPC2, and NPC1:NPC2 knock-out

murine models exhibited similar patterns of neuronal accumulation of free
cholesterol, GM2 and GM3 gangliosides suggesting that these proteins work
cooperatively in a common lipid transport pathway (Sleat et al., 2004). A study
performed by Infante et al. (2008), demonstrated that cholesterol binding to
NPC1 and its dissociation were mediated by NPC2, further supporting the
cooperative role of these two proteins.
Induction of autophagy has been observed in the NPC brain and other
pathologically affected organs, including hepatocytes and fibroblasts. Ko et al.
(2005) were the first to observe frequent autophagic vacuoles in NPC1 deficient
mice. Autophagy in NPC cells is mediated by the class III-PI3K/Beclin-1
complex and is hypothesized to be a stress-induced response (Pacheco et al.,
2007).

While NPC results in increased autophagosome production,

progression through the system is also impaired, as indicated by the report of
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accumulating ubiquitinated proteins (Liao et al., 2007).

The imbalance of

autophagosome production and degradation can lead to autophagic stress,
which may lead to neuronal dysfunction and ultimately cell death.
Autophagosome accumulations occur in additional LSDs including Pompe
disease (Raben et al., 2007), mucolipidosis type IV (Vergarajauregui and
Puertollano, 2008), multiple sulfatase deficiency and mucopolysaccharidosis
type IIIA (Settembre et al., 2008).
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CHAPTER 2
CATIONIC AMPHIPHILIC DRUG-TREATMENT RESULTS IN LYSOSOMAL
ACCUMULATION OF NON-ESTERIFIED STEROLS AND DELAYED
AUTOPHAGOSOME CLEARANCE

2.1 INTRODUCTION
The autophagosome is a double membrane vesicle that forms upon the
initiation of the autophagic process and transports cytosolic constituents to the
lysosome for degradation (Yang and Klionsky, 2010). Autophagy is a survival
mechanism used by the cell to maintain cellular homeostasis and clear
misfolded proteins and damaged organelles (Ishida et al., 2009; Mathew et al.,
2009). This process occurs continually at a basal level, but can be increased in
response to cellular stress. Even when autophagy is induced in response to
cellular stress, autophagosome synthesis and subsequent clearance is an
efficient process (Mizushima et al., 2004). Autophagosome accumulation can
result from one of three possibilities: 1) increased autophagosome synthesis
without compensatory increases in the rate of degradation; 2) suppressed
autophagosome turnover in the absence of increased rates of synthesis, or 3)
inhibition of autophagosome trafficking and/or autophagosome fusion. When
any of these conditions persist over a period of time, the cell is said to be under
autophagic stress (Chu et al., 2006).
Recent studies suggest that dysregulated autophagy may play an
important role in some human diseases.

For example, autophagosomes

produced in primary cortical neurons, in which autophagosome-lysosome
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fusion was inhibited, resembled the distinct characteristics of autophagosomes
present in AD neural cells (Boland et al., 2008).

In a study by Hara et al.

(2006), neural cell specific Atg5-/- mice were created to inhibit autophagy.
These mice exhibited ubiquitinated protein aggregates and symptoms of
neurological pathology.

This result suggested that proper autophagy is

necessary for maintaining neural cell health.
Niemann Pick type C disease (NPC) is a lysosomal storage disease
(LSD) that shows marked accumulation of autophagosomes. LSDs encompass
approximately 4-dozen inherited disorders, each being caused by a different
mutation/deficiency (Winchester et al., 2000). Although the basis for each LSD
disease differs, neuronal degeneration is a common complication to all
(Winchester et al., 2000; Bellettato and Scarpa, 2010). Murine in vivo studies,
in which essential autophagy genes are knocked-out, show ubiquitinated
protein aggregates, neurological symptoms including impaired locomotion and
motor coordination, and neurodegeneration (Komatsu et al., 2005; Hara et al.,
2006).

Alternatively, enhanced autophagosome clearance is able to clear

protein aggregates and relieve neurological symptoms (Sarkar et al., 2008).
NPC disease is due to the loss of function of NPC1 or NPC2 proteins,
which are necessary for proper cholesterol trafficking through the late
endosomal system. Therefore, it is not surprising that the hallmark of NPC
disease is the accumulation of non-esterified cholesterol within the late
endosomes and lysosomes due to lipid trafficking defects (Blom et al., 2003).
Coincidently, NPC cells also exhibit marked accumulation of autophagosomes
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(Ishibashi et al., 2009). Interestingly, analyses of biopsy material and cell lines
derived from additional LSD diseases such as GM1 Gangliosidosis (Takamura
et al., 2008), and Mucolipidosis Type IV (Vergarajauregui and Puertollano,
2008) also show marked accumulation of autophagosomes and lysosomal nonesterfied cholesterol.
Previous studies have examined the importance of organelle membrane
cholesterol

content.

Cholesterol

within

autophagosome

and

lysosome

membranes determines membrane fluidity and organization. When there is too
little cholesterol within endosome/lysosome membranes, autophagosomelysosome fusion is	
  impeded (Koga et al., 2010). Alternatively, when cholesterol
is enriched within endosome/lysosome membranes it impairs some types of
fusion events. This impairment includes phagosome-lysosome fusion, which is
a process analogous to autophagosome-lysosome fusion (Huynh et al., 2008).
Furthermore, this enrichement of cholesterol within late endosome/lysosome
membranes can lead to sequesteration or inactivation of factors needed for
fusion (Huynh et al., 2008, Fraldi et al., 2010).
U18666A (3-β-[2-(diethylamino)ethoxy]androst-5-en-17-one), along with
other cationic amphiphilic drugs (CAD) including imipramine, has been shown
to alter protein and lipid trafficking (Sato et al., 1998; Lange et al., 2000;
Lebrand et al., 2002; Suarez et al., 2004). A common side effect of CADs is the
manifestation of phospholipidosis, a condition involving the intracellular
accumulation of phospholipids and concentric lamellar bodies in lysosomes
(Halliwell, 1997). CAD induction of phospholipidosis varies between species,
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tissue type, and age groups, and is most likely due to the pharmacokinetic
differences among CADs (Halliwell, 1997).
CAD-induced phospholipidosis may be due to CADs directly binding to
phospholipids, which forms a complex that is more resistant to lysosomal
phospholipase degradation. The binding strength of CADs to phospholipids is
governed by the hydrophobic interactions of the nonpolar moieties of each
species of drug (Ma et al., 1985). This may explain the different effects of
CADs. In U18666A treated cells, cholesterol movement from the late
endosomes/lysosomes to the plasma membrane is inhibited resulting in the
massive accumulation of non-esterified cholesterol and sterols in late
endosomes and lysosomes. Therefore, U18666A is widely used in the study of
cholesterol transport and to simulate a NPC phenocopy (Sobo et al., 2007).
Due to the strong correlation between lysosomal non-esterified
cholesterol and autophagosome accumulation in NPC disease, I hypothesize
that autophagosome accumulation is a consequence of lysosomal nonesterified cholesterol accumulation. To test this hypothesis, I utilized the CAD
U18666A to induce a NPC phenocopy within the murine 1c1c7 hepatocyte cell
line.
Current studies were initiated to monitor the autophagic process within
the NPC phenotype, characterized by an accumulation of non-esterfied
cholesterol within late endosomes and lysosomes. Presently, the cause of
autophagosome accumulation in NPC is unclear. Some have proposed that
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autophagosome-lysosome fusion is inhibited due to lysosomal non-esterified
cholesterol

accumulation

autophagosome

(Liao

synthesis

et

greatly

al.,

2007).

outweighs

Others

suggest

degradation,

that

though

autophagosome-lysosome fusion and degradation remain functional (Pacheco
et al. 2007). In an effort to model the autophagic process within NPC, I	
  utilized
the CADs U18666A, imipramine, and clozapine to pharmacologically induce a
NPC phenocopy. The data presented in this chapter were obtained to further
explore the relationship between non-esterified cholesterol content and
autophagosome accumulation.
2.2 MATERIALS AND METHODS
2.2.1 Chemicals
U18666A was purchased from Calbiochem (San Diego, CA). Clozapine,
imipramine, 3-methyladenine (3-MA), bovine serum albumin (BSA), filipin,
bafilomycin

A1,

α-lipoic

acid,

Luminol,

p-coumaric

acid,

MgCl2, and

CaCl2⋅2H2O were purchased from Sigma (St. Louis, MO). FBS was purchased
from Hyclone (Logan, UT). Ethyl ether was purchased from Fisher Scientific
(Houston,

TX).

αMEM,

Earle’s

buffered

salt

solution,

penicillin

and

streptomycin, HEPES, MEM nonessential amino acids, vitamin MEM solution,
and Geneticin (G418) were purchased from Gibco-BRL (Carlsbad, CA).
Dialyzed FBS was purchased from Thermo Scientific (Chicago, IL). 3H-Leucine
was purchased from MP Biomedicals (Irvine, CA). Methanol was purchased
from EMD Chemicals (Gibbstown, NJ). Flo-Scint scintillation fluid was
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purchased from Radiomatic Instruments and Chemical Co. (Tampa, FL).
AlexaFluor 546 goat anti-rabbit IgG, AlexaFluor 546 goat anti-mouse IgG and
Slowfade solution were purchased from Molecular Probes (Eugene, OR).
2.2.2 Cell lines and culture conditions
1c1c7 murine hepatocyte cells or 1c1c7 cells stably expressing a GFPLC3 fusion protein (Reiners et al., 2010) were maintained in αMEM
supplemented with 5% FBS and 100 units/mL penicillin and 100 µg/mL
streptomycin at 37oC in a humidified atmosphere consisting of 95% air and 5%
CO2.

Cells expressing GFP-LC3 were maintained in the above medium

supplemented with 2 mg/mL Geneticin (G418). Experiments conducted with
GFP-LC3 cells used medium that did not contain G418.
The leucine-free starvation medium used in our studies consisted of
Earle’s balanced salts, 1x vitamin mix, 1x nonessential amino acids, 1%
dialyzed fetal bovine serum, 1 mM MgCl2, 1.8 mM CaCl2, 0.2 mg/L α-lipoic
acid, and 1 mM HEPES, pH 7.25.
2.2.3 Western blot analyses
Western blot analyses were performed using whole cell lysates to
determine levels of LC3, phosphorylated-p70S6K, p70S6K, and β-actin. To
prepare lysates, 1c1c7 cultures were washed with PBS and proteins were
extracted in insect lysis buffer (10 mM Tris pH 7.5, 130 mM NaCl, 1% Triton X100, 10 mM NaF, 10 mM NaPi, 10 mM NaPii) (BD Pharmingen, San Diego, CA)
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supplemented with 1x final concentration of protease inhibitor cocktail (Sigma,
St. Louis, MO). Protein extracts	
   were subjected to sodium dodecylsulfate
polyacrylamide gel electrophoresis (SDS-PAGE) on 12.5% or 15% acrylamide
gel and then transferred from the gel to nitrocellulose membrane. Nonspecific
antibody binding to transferred proteins was blocked by preincubating
membranes in 5% non-fat milk in tris-buffered saline solution containing 0.05%
Tween 20 (TBS-T) (20 mM Tris-HCl pH 7.6, 150 mM NaCl, and 0.05% Tween20). The membranes were incubated overnight with a rabbit polyclonal antibody
raised to microtubule-associated protein light chain 3 (LC3) (a gift from D.
Kessel, Wayne State University) or a rabbit polyclonal antibody raised to detect
phosphorylation at the threonine 389 position of p70S6K (Cell Signaling,
Boston, MA) or a p70S6K panning antibody to detect total p70S6K protein (Cell
Signaling, Boston, MA), or a murine monoclonal antibody that recognizes the
N-terminus of murine β-actin (Sigma, St. Louis, MO). Membranes were
subsequently washed with TBS-T and incubated with the appropriate
horseradish peroxidase coupled secondary antibody for 1.5 h at room
temperature. Antibody-antigen complexes were detected by using a home
made ECL solution (0.1 M Tris-HCl, pH 8.5, 250 mM Luminol, 90 mM pcoumaric acid, 0.8 mM H2O2) and standard ECL visualization methods.
Western blots were developed on x-ray film and quantified by Image J software.
2.2.4 Fluorescence microscopy
All studies involving analyses of cellular fluorescence were performed
with cells grown on poly-L-lysine coated coverslips or in 35 mm glass bottom
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microwell dishes. Digital images were captured with a Zeiss Axiovert 200M
fluorescence microscope, equipped with an ApoTome (Carl Zeiss, Cologne,
Germany) and capable of z plane scanning. Images were imported into Adobe
Photoshop for cropping and	
   sizing. Images within a figure subpanel were
always taken using identical conditions, unless specifically noted in the figure
legend. Any post capture manipulations of images (brightness or contrast) were
uniformly applied to all images within a panel group. MetaMorph Imaging
Software (Molecular Devices Corp, Sunnyvale, CA) was used to quantify filipin
staining intensity in individual cells and autophagosome content. Filipin staining
intensities are reported in arbitrary units.
2.2.5 Sterol detection
To detect nonesterified cholesterol/sterols, the naturally fluorescent
antibiotic filipin was utilized due to its high affinity for sterol molecules that
contain the 3β-hydroxy group (Gimpl and Gehrig-Burger, 2007). Cultures were
washed three times with phosphate-buffered saline (PBS) and fixed with 4%
paraformaldehyde/PBS (w/v) for 30 min at room temperature. After three
washes with PBS the cells were incubated with 100 mM glycine/PBS for 10 min
and stained with filipin (9.05 mg/ml in 5% BSA/PBS (w/v)) for 2 h. All steps
were performed at room temperature. Cells were subsequently washed with
PBS and coverslips were inverted onto a drop of SlowFade solution on a glass
slide. Digital images were captured with a Zeiss Axiovert 200M fluorescence
microscope using a filter set consisting of 365 nm excitation, 395 nm dichroic
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mirror, and 420 nm long pass emission filter. Filipin was initially prepared in
DMSO.
2.2.6 Sterol colocalization with LAMP1
Cultures were washed three times with PBS and fixed with 4%
paraformaldehyde/PBS (w/v) for 30 min at room temperature. After the
coverslips were washed three times with PBS the cells were incubated in a 5%
BSA/PBS (w/v) solution for 1 h at room temperature to block nonspecific
immunoglobulin binding.	
   The cells were then incubated with a 5% BSA/PBS
(w/v) solution containing 1:1000 1D4B rat anti-mouse LAMP1 antibody
(Developmental Studies Hybridoma Bank, University of Iowa) and 9.05 mg/mL
filipin, in the dark for 2 h at room temperature. The coverslips were
subsequently washed with PBS followed by incubation with a 1:200 dilution of
AlexaFluor 546 goat anti-rabbit IgG in blocking buffer in the dark for 1 h at 37
°C. The coverslips were washed three times with PBS and inverted onto glass
slides with a drop of SlowFade solution and sealed with acrylic nail polish. One
micrometer z-plane images were captured using an Apotome optical sectioning
device. LAMP1 (red) and filipin (green) assigned fluorescence was captured
using a filter set consisting of 546 nm excitation, 580 nm dichroic mirror, and
590 nm emission and 365 nm excitation, 395 nm dichroic mirror, 420 nm
longpass emission, respectively.
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2.2.7 GFP-LC3 colocalization with LAMP1 and cathepsin D
In order to colocalize GFP-LC3 with lysosomal LAMP1 or cathepsin D
cultures

were

washed

three

times

with

PBS

and

fixed

with

4%

paraformaldehyde/PBS (w/v) for 30 min at room temperature. Fixed cultures
were subsequently washed 3x with PBS/0.1% saponin, and incubated in
blocking buffer (5% BSA/PBS/0.1% saponin) for 1 h at 37oC to inhibit nonspecific immunoglobulin binding. The coverslips were washed three times and
then incubated with 1:1000 cathepsin D antibody (CalbioChem, San Diego,
CA), or 1:1000 1D4B rat anti-mouse LAMP1 antibody in blocking buffer for 2 h
at 37oC. The coverslips were washed three times followed by incubation with
1:200 dilution of AlexaFluor 546 goat anti-rabbit IgG or AlexaFluor 546 goat
anti-mouse IgG (Molecular Probes, Eugene, OR) in blocking buffer for 1 h at
37oC. The coverslips were again washed three times and inverted onto glass
slides with a drop of Slowfade solution (Molecular Probes, Eugene, OR) and
sealed with acrylic nail polish. GFP-LC3 and AlexaFluor 546 fluorescence was
captured using filter sets consisting of 450-490 nm excitation, 510 nm dichroic
mirror, 515-565 nm emission, and 546 nm excitation, 580 nm dichroic mirror,
and 590 nm long pass emission, respectively.
2.2.8 Visualization of GFP-LC3
To detect only GFP-LC3 fluorescence, 1c1c7 cultures containing GFPLC3

were

washed

three

times

with

PBS

and

fixed

with

4%

paraformaldehyde/PBS (w/v) for 30 min at room temperature. The coverslips
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were again washed three times and inverted onto glass slides with a drop of
Slowfade solution (Molecular Probes, Eugene, OR) and sealed with acrylic nail
polish. GFP-LC3 fluorescence was captured using filter sets consisting of 450490 nm excitation, 510 nm dichroic mirror, and 515-565 nm emission. GFP-LC3
puncate spots were quantified using Metamorph Imaging Software and were
measured by setting the fluorescence intensity threshold to a level where only
fluorescent punctate spots were selected. The software program then counted
the numbers of selected punctate spots in individual cells.
2.2.9 Autophagosome Clearance Protocol
GFP-LC3-expressing 1c1c7 cells were plated on poly-L-lysine coated
coverslips at a density that ensured subconfluence at the end of the
experiment. Cultures were treated with either (a) 1µM U18666A for 36 h, (b) 10
µM clozapine for 36 h, (c) 30 nM rapamycin for 3 h, or (d) leucine-free medium
for 3 h prior to the addition of 3-methyladenine (3-MA, 5 mM final
concentration). Cultures were subsequently washed and fixed at various times
after 3-MA addition. Because autophagosome clearance was very slow in CADtreated cultures, medium containing both CAD and 3-MA was replaced every
12 h. Additional cultures were (e) treated with U18666A or clozapine for 36 h
prior to being shifted to leucine-free medium that contained both CAD and 5
mM 3-MA. These cultures were subsequently washed and fixed at selected
times after the switch to leucine-free medium. Fixed cells were washed three
final times with PBS and inverted onto glass slides with a drop of Slowfade
solution. GFP fluorescence was captured and quantified as described above.
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Autophagosome half-lives were calculated from analyses of semi-log graphs
(Prism, Graphpad Software, San Diego, CA).
2.2.10 Functional Assay
Degradation of long-lived protein was measured using a modified
version of a procedure published by Mordier et al. (2000). Cells were plated in
60 mm dishes at a density such that cultures would be 70-80% confluent at the
end of the experiment. Approximately 24 h after plating, the cultures were
washed and refed with complete αMEM growth medium containing 1 µCi/ml 3Hleucine for ~18 h. Thereafter, the cells were washed with PBS and refed with
complete αMEM supplemented with 2.8 mM leucine. After a 12 h chase, the
cultures were again washed and refed with complete αMEM + 2.8 mM leucine
± 0.75 µM U18666A. Sampling began immediately before, and 12, 24 and 36 h
after culture medium change. Three 0.8 mL medium samples were removed at
each time point. Each sample was adjusted with trichloroacetic acid (TCA) and
BSA to 10% and 5 mg/ml, respectively, and stored at 4oC to allow protein
precipitation. Thereafter, the samples were centrifuged at 15,000g for 5 min at
37oC. Supernatant fluids were removed and set aside for measurement of
radioactivity (fraction #1). The resulting pellet fraction was washed with 20%
TCA, recentrifuged, and the resultant supernatant fluids were added to fraction
#1. The pellet was dissolved in 0.2 M NaOH and assayed for radioactivity
(fraction #2). Cells attached to the culture plates were washed twice with PBS
prior to being sequentially incubated on ice with cold 5% TCA for 1 h, washed
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2x with 5% TCA, washed 3x with 0.5 mL of ethyl ether/methanol (1:4 v/v), and
then allowed to dry. Once dry, the cells were solubilized by incubation with 0.2
M NaOH for 18 h prior to being analyzed for radioactivity by scintillation
counting (fraction #3). Percent proteolysis was calculated as dpm in fraction #1
divided by the sum of the dpm in all three fractions multiplied by 100. These
studies employed 3 culture dishes per treatment and time point.
In an additional experiment, cells were plated in 60 mm dishes at a
density such that cultures would be 70-80% confluent at the end of the
experiment. Approximately 24 h after plating the cultures were washed and
refed with complete αMEM growth medium containing 1 µCi/ml 3H-leucine for
~18 h. Thereafter, the cells were washed with PBS and refed with complete
αMEM supplemented with 2.8 mM leucine. After a 12 h chase the cultures were
again washed and refed with complete αMEM + 2.8 mM leucine ± 0.75 µM
U18666A. At 36 h following culture medium change, cultures were shifted to
leucine-free medium or refed with complete αMEM + 2.8 mM leucine. 0.75 µM
U18666A was added to the appropriate samples. Samples were collected at 0,
2, 4, 6, or 8 h and processed using the method described above.
2.2.11 Statistical Analysis
Data were analyzed by one-way ANOVA or two-way ANOVA and
Bonferroni post-hoc test (Prism, Graphpad Software, San Diego, CA).
Differences between/among groups were scored as statistically significant if P
<0.05.
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2.3 RESULTS	
  
2.3.1

U18666A-treatment

induces

lysosomal

non-esterified

cholesterol/sterol accumulation in late endosomes and lysosomes
The fluorescent antibiotic filipin has a high affinity for sterol molecules
that contain a 3β-hydroxyl group and is commonly used to detect non-esterified
cholesterol/sterols (Gimpl and Gehrig-Burger, 2007). As stated previously,
U18666A is widely used to mimic the effects of NPC through the inhibition of
cholesterol transport. Utilizing the 1c1c7 murine hepatoma cell line, cultures
were treated with varying concentrations of U18666A (0.1 – 1 µM) for 24 h (Fig.
5A). Exposure of cultures to U18666A for 24 h resulted in a concentrationdependent loss of diffuse filipin staining and a reciprocal gain in punctate
perinuclear staining (Fig. 5A). In order to quantify filipin staining over the range
of U18666A concentrations images were captured using a manually set, fixed
exposure time (Fig. 5A, bottom row). Metamorph analyses of per cell filipin
fluorescence intensities captured using a fixed exposure period are presented
in Fig. 5B. Statistically significant increases in filipin staining were observed
within 24 h of treatment with 0.1 µM U18666A, although concentrations as low
as 10 nM reproducibly resulted in some increase above background (n=3
experiments). Subsequent studies employed 1 µM U18666A as the working
concentration because it appeared to represent a saturating concentration (Fig.
5B).
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Exposure of 1c1c7 cultures to 1 µM U18666A for periods longer than 24

h (24-96 h) enhanced the intensity of filipin staining (Fig. 6A). Metamorph
analyses of per cell filipin fluoresence intensities captured using a fixed
exposure period are presented in Fig. 6B. Although the log scale employed in
Fig. 6B tends to minimize differences, filipin staining intensity continued to
increase over a 96 h treatment period (Fig. 6B).
Several investigators have used a variety of protocols to demonstrate
that the U18666A-induced perinuclear filipin-stained punctate structures
correspond to late endosomes/lysosomes (Kobayashi et al., 1999, Hall et al.,
2003, Lajoie et al., 2005). LAMP1 is a marker of late endosomes/lysosomes
and extensively co-localized with filipin in U18666A-treated 1c1c7 cultures (Fig.
7). A similar co-localization was not observed in non-treated cultures (Fig. 7).
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Figure 5: U18666A-induced cholesterol accumulation is concentrationdependent in 1c1c7 cells. (A) 1c1c7 cultures were treated with 0.01–1 µM
U18666A for 24 h prior to being fixed and stained with filipin. Images were
captured either with variable exposure times (top panel) or 10 ms fixed
exposure time (bottom panel). (B) Per cell quantification of filipin fluorescence
in cultures depicted in the lower portion of panel A using a fixed exposure
period. Data represent means ± SD of 24-38 cells per treatment group taken
from multiple independent fields of cells. *Significantly greater than non-treated
cultures and 0.01 µM U18666A-treatment group, P<0.05. **Significantly greater
than non-treated and ≤ 0.1 µM U18666A treatment groups, P<0.05. White bars
in panel A equals 20 microns.
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Figure 6: U18666A-induced cholesterol accumulation is time-dependent in
1c1c7 cells. (A) 1c1c7 cultures were treated with 1 µM U18666A for 24-96 h
prior to being fixed and stained with filipin. Images were captured either with
variable exposure times (top panel) or a 10 ms fixed exposure time (bottom
panel). (B) Per cell quantification of filipin fluorescence in cultures depicted in
panel A using a fixed exposure period. Data represent means ± SD of 20-41
cells per treatment group taken from multiple independent fields of cells.
*Significantly greater than no treatment group, P<0.05. **Significantly greater
than non-treated and ≤ 48 h treatment groups, P<0.05. White bars equal 20
microns.
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Figure 7: Filipin-stained puncatate spots correspond to late
endosomes/lysosomes in CAD-treated cells. 1c1c7 cultures were treated
with 1 µM U18666A, 10 µM clozapine (CZP) or 10 µM imipramine (IMP) for 48
h prior to the processing of cultures for staining with filipin and LAMP1. Filipin
fluorescence was assigned a ‘green’ color so that colocalization with ‘red’
LAMP1 would appear as yellow. White bar equals 20 microns.
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2.3.2 U18666A-treatment induces autophagosome accumulation in 1c1c7
cells
1c1c7 cultures that stably expressed a GFP-LC3 fusion protein exhibited
diffuse GFP fluorescence (Fig. 8A). Exposure to U18666A resulted in
concentration-dependent (Fig. 8A and B) and time-dependent (Fig. 9A and B)
coalescence of GFP-LC3 into highly fluorescent punctate structures. These
structures most likely correspond to autophagosomes, and were detected
within 48 h of treatment with 1 µM U18666A (Fig. 8A,B and Fig. 9A,B).
Thereafter, their number per cell continued to increase with time (Fig. 9A and
B). Interestingly, per cell filipin staining intensity and autophagosome content
increased in parallel as the concentration of U18666A rose from 10 nM to 1 µM
(compare Figs. 5A and 8A).
The conclusion that U18666A exposure induced autophagy was
confirmed by monitoring the conversion of LC3-I to LC3-II. Exposure of 1c1c7
cultures to U18666A resulted in a concentration-dependent accumulation of
LC3-II during the first 48 h (Fig. 8C) that paralleled increases in per cell
autophagosome content (Fig. 8A). LC3-II content remained elevated following
continued culturing in the presence of U18666A (Fig. 9C).
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Figure
8:
U18666A-induced
autophagosome
accumulation
is
concentration-dependent in 1c1c7 cells. (A) Cultures of 1c1c7 cells stably
expressing a GFP-LC3 fusion protein were treated with 0.01-1 µM U18666A for
48 h prior to being fixed and imaged. White bar equals 20 microns. (B) Per cell
quantification of autophagosomes in cultures depicted in panel A. Data
represent means ± SD of 8-10 cells per treatment group. *Significantly greater
than non-treated cultures, P<0.05. **Significantly greater than all lower
concentrations of U18666A, P<0.05 (C) Non GFP-expressing 1c1c7 cultures
were treated with 0.01-1 µM U18666A for 48 h before being harvested and
processed for Western blot analyses of LC3 and β-actin. Each lane contained
25 µg of protein lysate. Similar results were obtained in a second independent
experiment.
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Figure 9: U18666A-induced autophagosome accumulation is timedependent in 1c1c7 cells. (A) Cultures of 1c1c7 cells stably expressing a
GFP-LC3 fusion protein were treated with 1 µM U18666A for 24-96 h prior to
being fixed and imaged. (B) Per cell quantification of autophagosomes in
cultures depicted in panel A. Data represent means ± SD of 15 cells per
treatment group. *Significantly greater than non-treated cultures, P<0.05. (C)
Non GFP-expressing 1c1c7 cultures were treated with 1 µM U18666A for 24-96
h before being harvested and processed for Western blot analyses of LC3 and
β-actin. Each lane contained 25 µg of protein lysate. Similar results were
obtained in a second independent experiment.
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2.3.3 CAD-induced late endosomal and lysosomal accumulation of nonesterified cholesterol in 1c1c7 cells
As discussed above, U18666A is a member of a class of cationic
amphiphilic drugs that are collectively referred to as CADs. Similar to the
effects of U18666A, treatment of 1c1c7 cultures with the CADs clozapine (Fig.
10A and B) or imipramine (Fig. 10D and E) resulted in the time-dependent
accumulation of filipin-stained punctate structures. Colocalization analyses of
filipin and LAMP1 confirmed that the filipin-stained punctate structures in the
CAD-treated cultures represented late endosomes/lysosomes (Fig. 7). The
accumulation of punctate-filipin stained structures following 10 µM clozapine or
imipramine treatment was accompanied by the induction of autophagy, as
monitored by the coalescence of GFP-LC3 into punctate spots (Fig. 10A,C,D,
and F).
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Figure 10: Concurrent cholesterol and autophagosome accumulation is a
general characteristic of CAD-treatment in 1c1c7 cells. 1c1c7 cultures were
treated with 10 µM clozapine (A) or 10 µM imipramine (D) for 24-96 h prior to
being harvested for analyses of filipin binding (top row of panels) or GFP-LC3
fluorescence (bottom row of panels). White bar represents 20 microns. Per cell
quantification of filipin fluorescence (B) and autophagosome number (C) in
cultures depicted in panel A. Data represent means ± SD of 6-26 cells per
treatment. Per cell quantification of filipin fluorescence (E) and autophagosome
number (F) in cultures depicted in panel D. Data represent means ± SD of 7-16
cells per treatment group. *Significantly greater than non-treated cultures,
P<0.05. **Significantly greater than non-treated cultures and values at
preceding times of harvest, P<0.05.
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2.3.4 Loss of lysosomal non-esterified cholesterol correlates wtih
autophagosome clearance
To

determine

if

the

accumulation

of

lysosomal

non-esterified

cholesterol/sterol content was a permanent consequence of U18666A
treatment, ‘wash-out’ experiments were performed where U18666A was
omitted from the culture medium after sustained exposure to U18666A for 96 h.
U18666A-mediated accumulation of lysosomal non-esterified cholesterol/sterol
was reversed following ‘wash-out’ of U18666A (Fig. 11A and B). In the specific
experiment reported in Fig. 11A and B, filipin intensities were ~103-fold greater
than control cultures following 96 h of U18666A exposure, but only 10-fold and
3-fold greater after 3 and 4 days of washout, respectively. These decreases in
filipin staining were paralleled by concurrent decreases in autophagosomes, as
monitored by either the occurrence of GFP-LC3 fluorescent punctate structures
(Fig. 11A and C) or LC3-II expression (Fig. 11D). This coordinate accumulation
and loss is suggestive of a relationship between lysosomal non-esterified
cholesterol and autophagosome content.
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Figure 11: Coordinate reversal of U18666A-induced cholesterol and
autophagosome accumulation in 1c1c7 cells. 1c1c7 cultures were treated
with 1 µM U18666A for 96 h prior to being washed, replated in fresh medium
lacking U18666A, and subsequently imaged/processed at varied times after
being replated. (A) Non GFP-LC3 cultures were stained with filipin to monitor
non-esterified cholesterol accumulation by fluorescence microscopy (top row).
GFP-LC3 expressing cultures were imaged by fluorescence microscopy to
detect autophagosome formation (bottom row). White bar in panels represents
20 microns. (B) Per cell quantification of filipin fluorescence in cultures depicted
in the top row of panel A. Data represent means ± SD of 26-47 cells per
treatment group taken from multiple independent fields of cells. *Significantly
greater than non-treated (NT) cultures, P<0.05. (C) Per cell quantification of
autophagosomes in cultures depicted in the bottom row of panel A. Data
represent means ± SD of 10-18 cells per treatment group. *Significantly greater
than NT control, P<0.05. (D) Non-GFP cultures were not treated (NT) or treated
(T) as described above and harvested at indicated times for western blot
analyses of LC3 and β-actin. Each lane used 25 µg of protein lysate. Western
blot data similar to that presented in panel D were obtained in two additional
experiments.
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2.3.5 Reduced autophagosome and lysosome fusion in U18666A-treated
cultures
Autophagosomes accumulate as a consequence of an imbalance in their
rates of synthesis and degradation. Whereas several studies document
enhanced autophagosome formation in U18666A–treated cultured cells
(Pacheco et al., 2007, Settembre et al., 2008, Ishibashi et al., 2009), little
attention has been paid to possible U18666A effects on autophagosome
degradation. In order to visualize autophagosome–lysosome fusion I attempted
to colocalize GFP-LC3 with the lysosomal proteins cathepsin D or LAMP1. In
control cultures GFP-LC3 fluorescence was diffuse, whereas both cathepsin D
and LAMP1 exhibited distinct punctate fluorescence (Fig. 12). U18666A
exposure stimulated the coalescence of GFP-LC3 into punctate spots, and
altered the distribution of the cathepsin D and LAMP1 positive punctate spots
such that they were more perinuclear (Fig. 12). A limited number of U18666Ainduced GFP-LC3 punctate spots colocalized with cathepsin D or LAMP1.
Hence, autophagosome–lysosome fusion occurs in U18666A-treated cultures.
However, the extent of fusion is markedly less than what occurs following a
strong autophagic stimulus in response to leucine-starvation (Fig. 12). Unlike
what was observed in U18666A cultures, a considerable portion of the
starvation-induced autophagosomes fused with lysosomes, as indicated by the
colocalization of LAMP1 and GFP-LC3 and the development of yellow puncta.
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Figure 12: Autophagosomes do not readily colocalize with lysosomes in
U18666A-treated 1c1c7 cells. GFP-LC3 expressing cultures were treated with
1 µM U18666A for 48 h or left untreated. Some non-treated cultures were
shifted to a leucine-free ‘starvation’ medium for 6 h. At the time of analyses
cultures were fixed and subsequently immunostained with anti-cathepsin D or
anti-LAMP1. Colocalization of GFP-LC3 with either cathepsin D or LAMP1 in Z
plane sections is indicated by yellow/orange punctate spots. Inset images are
magnifications of the area indicated by the white box. White bar represents 10
microns.
	
  
	
  
	
  
	
  
	
  
	
  
	
  

	
  

	
  

61	
  

2.3.6 Imbalanced autophagic flux in CAD treated 1c1c7 cells
Because the autophagic pathway is the major route for the degradation
of long-lived proteins, the turnover of radiolabeled proteins remaining after a
long chase period is commonly used to monitor autophagic functionality (Henell
et al., 1987). To this end, 1c1c7 cultures were labeled with 3H-leucine for 18 h
and then chased with fresh complete medium containing 2.8 mM leucine for 12
h to insure degradation of all short-lived proteins. Cultures were subsequently
refed, and either left untreated or exposed for 12, 24 or 36 h to U18666A prior
to being harvested. U18666A treatment did not alter the kinetics of labeled
protein degradation

(Fig. 13). In essence, U18666A-treated cultures

maintained the same constitutive level of autophagic degradation as observed
in non-treated cultures despite the increased presence of autophagosomes.
As a quantitative measure of ‘autophagic flux’, a term used to describe
autophagosome generation and degradation, I monitored LC3-II levels following
the addition of either bafilomycin A1 or NH4Cl to nontreated or U18666Atreated cultures. Both agents facilitate the accumulation of LC3-II by
neutralizing lysosomal pH, resulting in the suppression of degradation by
lysosomal proteases (Mizushima et al., 2010). In addition, bafilomycin A1 may
also suppress autophagosome–lysosome fusion (Yamamoto et al., 1998). Both
bafilomycin A1 and NH4Cl induced LC3-II accumulation in 1c1c7 cultures
independent of any other treatment (Fig. 14). When added to U18666A-treated
cultures, both agents induced accumulation of LC3-II to levels that were greater
than those occurring in cultures treated with only U18666A or either inhibitor.
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This result suggested that not only does U18666A-treatment increase
autophagosome synthesis, but some of the autophagosomes arising as a
consequence of U18666A treatment eventually fuse with lysosomes. Similar
LC3-II patterns occured when performing the same protocol using clozapine or
imipramine-treated 1c1c7 cultures (Fig. 15A and B). This suggests that an
imbalance of autophagic flux may be a general consequence of CADs.
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Figure 13: Long-lived protein turn-over is not altered in U18666A-treated
1c1c7 cells. 1c1c7 cultures were labeled with 3H-leucine for 18 h, and
subsequently subjected to a 12 h chase with medium containing 2.8 mM
leucine before being refed ± 0.75 µM U18666A. Culture medium and cells were
subsequently harvested and processed as described in ‘Materials and Methods’
in order to monitor protein degradation. Data are means ± SD of three cultures
per time and treatment group. Similar results were obtained in 2 additional
studies.
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Figure 14: Autophagic “flux” in U18666A-treated 1c1c7 cells. Cultures were
nontreated, or treated with 1 µM U18666A for 48 h prior to the addition of 1 mM
NH4Cl or 100 nM bafilomycin A1 (Baf) for 3 h prior to being harvested for
Western blot analyses of LC3 and β-actin. Each lane contained 25 µg of
protein. Similar results were obtained in 2 additional studies. Numbers indicate
quantification of Western blot analysis and were calculated by normalizing LC3II expression to actin expression. Nontreated values were set to 1 and
subsequent values were compared to the corresponding nontreated value.
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Figure 15: Autophagic “flux” in clozapine- and imipramine-treated 1c1c7
cultures is similar to U18666A-treated cells. Cultures were left nontreated, or
treated with (A) 10 µM imipramine (IMP) or (B) 10 µM clozapine (CZP) for 48 h
prior to the addition of 100 nM bafilomycin A1 (Baf) for 3 h or 5 h. Cultures were
subsequently harvested for Western blot analyses of LC3 and β-actin. Each
lane contained 25 µg of protein. Similar results were obtained in 2 additional
studies. Numbers indicate quantification of Western blot analysis and were
calculated by normalizing LC3-II expression to actin expression. Nontreated
values were set to 1 and subsequent values were compared to the
corresponding nontreated value.
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2.3.7 Starvation-induced fusion of lysosomes with U18666A-derived
autophagosomes
Given the rapid and significant extent of lysosome-autophagosome
fusion occurring in cultures shifted to leucine-free medium (Fig. 12), I wanted to
determine if shifting U18666A-treated cultures to leucine-free medium would
enhance the fusion of lysosomes with U18666A-induced autophagosomes.
Prior to initiating this study I determined the extent to which leucine starvation
facilitated the conversion of LC3-I to LC3-II (Fig. 16A). Starvation is a wellknown inducer of autophagy (Mordier et al., 2000; Kristensen et al., 2008).
Unexpectedly, I observed little to no accumulation of LC3-II when compared to
nontreated cultures following the shift to leucine-free medium (Fig. 16A).
Starvation-induced autophagy is described as a highly efficient process and
appears to be occurring at a rate only detectable when autophagosome
degradation is inhibited. Co-treatment with bafilomycin A1 at the time of the
shift caused LC3-II accumulation greater than that observed in cultures treated
with only bafilomycin A1, indicating an increase in ‘autophagic flux’. (Fig. 16A).
Shifting U18666A-treated cultures to a leucine-free medium reduced U18666Ainduced LC3-II expression (Fig. 16B). Decreases in LC3-II were obvious within
3 h of the shift, and very pronounced within 3 h. LC3-II expression was fairly
similar in U18666A + bafilomycin A1 and U18666A + bafilomycin A1 +
starvation treatment groups, which in turn were greater than LC3-II expression
in the U18666A ± starvation treatment groups (Fig. 16B). These data suggest
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that the degradation of U18666A-induced autophagosomes could be enhanced
with the addition of the leucine-starvation stimulus.
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Figure 16: Enhanced autophagosome degradation in U18666A-treated
1c1c7 cells under leucine-starvation conditions. (A) 1c1c7 cultures were
treated with 100 nM bafilomycin A1 (Baf), or shifted to a leucine-free medium
(Starve), or subjected to both starvation and Baf treatment for 2, 3 or 5 h prior
to being harvested for Western blot analyses of LC3 and β-actin. (B) Additional
cultures were treated with 1 µM U18666A for 48 h prior to being exposed to 100
nM Baf and/or being shifted to leucine-free medium. Cultures were harvested 2,
3 or 5 h after treatment/shift for Western blot analyses of LC3. Results similar to
those reported in panels A and B were obtained in two additional studies.
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Analyses of LAMP1 and GFP-LC3 colocalization by fluorescence

microscopy confirmed the occurrence of enhanced ‘autophagic flux’ in cultures
shifted to leucine-free medium (Fig. 17A). Autophagosomes (i.e., GFP-LC3
punctate spots) were detectable within 2-8 h of medium shift. Autophagosomelysosome fusion, as monitored by the colocalization of LAMP1 with GFP-LC3
and the appearance of yellow puncta, occurred during this observation period
at a level significantly greater than that observed in autophagosome-laden
U18666A-treated cells (Fig. 17A, second column from the right). Fluorescence
colocalization studies support the interpretation made from the Western blot
data in Fig. 16B. Specifically, a significant degree of LAMP1 and GFP-LC3
colocalization was observed within 2 h of shifting U18666A-treated cultures to
leucine-free medium, and maintained for the next 6 h (Fig. 17A).

These

findings strongly suggest that the leucine-starvation protocol stimulates the
fusion of lysosomes with pre-existing U18666A-derived autophagosomes.
As previously mentioned, the strong correlation between lysosomal nonesterified cholesterol and autophagosome accumulation has led some to
speculate a cause-and-effect relationship (Settembre et al., 2008; Liao et al.,
2007; Ishibashi et al., 2009). If this speculation were correct, one would also
expect leucine-starvation to remove lysosomal non-esterified cholesterol.
Interestingly, shifting non-treated 1c1c7 cultures to leucine-free media did not
alter filipin staining intensity (Fig. 17B). Instead, leucine starvation dramatically
affected the filipin staining pattern of U18666A-treated cultures (Fig. 17A,
bottom two rows). Although filipin staining remained punctate, the stained
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punctate structures appeared to disperse (Fig. 17A). These data, in conjunction
with the ability of leucine deprivation to trigger rapid autophagosome-lysosome
fusion in U18666A-treated cultures, suggest that elevated lysosomal nonesterified cholesterol content does not markedly hinder the fusion process.
As an additional method to monitor autophagic flux under the leucinestarvation protocol, I monitored radiolabeled long-lived protein degradation (Fig.
18). 1c1c7 cultures were labeled with 3H-leucine for 18 h and then chased with
fresh complete medium containing 2.8 mM leucine for 12 h to insure
degradation of all short-lived proteins. Cultures were then refed, and either left
untreated (Fig. 18A) or exposed for 36 h to U18666A (Fig. 18B). Cultures were
subsequently shifted to leucine free medium ± U18666A or to fresh complete
medium containing 2.8 mM leucine ± U18666A prior to being harvested at 2, 4,
6 or 8 h. Leucine-starvation of non-treated cultures dramatically increased longlived protein degradation as expected (Roberts and Deretic, 2008) (Fig. 18A).
Similarly, cultures treated with U18666A for 36 h prior to leucine-starvation
showed an increase in labeled protein degradation following medium shift (Fig.
18B). These findings support the results observed in Fig. 16B and indicate that
leucine-starvation of U18666A-treated cultures resulted in an increase in longlived protein turnover and the enhanced degradation of U18666A-induced
autophagosomes.
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Figure 17: Enhanced autophagosome-lysosome fusion in U18666Atreated 1c1c7 cells under leucine-starvation conditions. (A) 1c1c7 GFPLC3 expressing and non-expressing cultures were treated with 1 µM U18666A
(UA), or nontreated (NT) for 48 h prior to shifting some cultures to leucine-free
medium for 2, 4, 6 or 8 h. At the time of harvest cultures were fixed and stained
with filipin (non GFP-LC3 expressing) or immunostained with anti-LAMP1
(GFP-LC3 expressing). Colocalization of GFP-LC3 (green) with LAMP1 (red) in
Z plane sections is indicated by yellow/orange punctate spots. White bar in
panel A top row represents 10 microns and white bar in the second row from
the bottom represents 20 microns. (B) Per cell quantification of filipin
fluorescence in cultures depicted in panel A. Data represent means ± SD of 1430 cells per treatment group taken from multiple independent fields of cells.
*Significantly greater than nontreated control, P<0.05.
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Figure 18: Long-lived protein turnover in U18666A-treated 1c1c7 cells is
enhanced by leucine-starvation. 1c1c7 cultures were labeled with 3H-leucine
for 18 h, and subsequently subjected to a 12 h chase with medium containing
2.8 mM leucine before being refed ± 0.75 µM U18666A for 36 h. (A) NonU18666A-treated cultures were maintained in complete medium containing 2.8
mM leucine (Nontreated) or were shifted to leucine-free medium (NontreatedST). (B) U18666A containing cultures were refed with fresh complete medium
containing 2.8 mM leucine and U18666A (U18666A) or were shifted to leucinefree medium containing U18666A (U18666A-ST). Culture medium and cells
were harvested at 2, 4, 6 or 8 h and processed as described in ‘Materials and
Methods’ in order to monitor protein degradation. Data are means ± SD of three
cultures per time and treatment group. Similar results were obtained in 2
additional studies.
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2.3.8 Starvation-induced autophagosome clearance is not mTORdependent
The mTOR signaling pathway is a potent negative regulator of autophagy
(Nobukuni et al., 2005). Leucine starvation stimulates autophagy through the
mTOR pathway (Pacheco et al., 2007). Conditions resulting in nutrient/energy
depletion often result in the suppression of mTOR activity, and the induction of
autophagy. In the previous set of experiments, leucine starvation was able to
enhance U18666A-induced autophagosome degradation and induce a
moderate dispersal of lysosomal non-esterified cholesterol as demonstrated by
filipin staining. In order to assess the effects of U18666A and leucine-free
medium on mTOR, I monitored the phosphorylation status of ribosomal S6
kinase (p70 S6K), a downstream substrate of the kinase activity of mTOR by
Western blot analysis (Scott et al., 2004). p70 S6K was phosphorylated on the
Thr389 position in both non-treated control and U18666A-treated cultures (Fig.
19). Shifting control cultures to a leucine-free medium almost completely
eliminated the phosphorylated form of p70 S6K within 2 h, and greatly reduced
phosphorylated p70 S6K expression in U18666A-treated cultures. Within 3 h of
shifting to leucine-free medium the phosphorylated form of p70 S6K was
eliminated in both control and U18666A-treated cultures (Fig. 19).
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Figure 19: Inhibition of the mTOR pathway in U18666A-treated 1c1c7 cells
under leucine starvation-conditions. 1c1c7 cultures were left untreated or
exposed to 1 µM U18666A for 48 h before being shifted to a leucine-free
medium for 2, 3 or 5 h prior to being harvested for Western blot analyses of pp70 S6K (p-S6K), p70 S6K (S6K) and β-actin. Each lane contained 25 µg of
protein.
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The above studies raised the issue of whether mTOR is responsible for

modulating lysosome-autophagosome fusion in U18666A-treated 1c1c7
cultures. Rapamycin is a widely used inhibitor of mTOR (Sarbassov et al.,
2006), and suppressed mTOR activity in both control and U18666A-treated
cultures as demonstrated by Western blot analysis (Fig. 20). Unlike what was
observed following a shift to leucine-free media, rapamycin induced LC3-II
accumulation by itself, and enhanced LC3-II accumulation in U18666A-treated
cultures (Fig. 20). Analyses of GFP-LC3 fluorescence confirmed that rapamycin
induced autophagosomes within 2 h of addition (Fig. 21A). Analyses of GFPLC3 and LAMP1 co-localization, as indicated by yellow punctate spots, showed
that autophagosome-lysosome fusion occurred with rapamycin treatment alone.
However, rapamycin did not enhance lysosome fusion with U18666A-induced
autophagosomes (Fig. 21A). Hence, the enhanced autophagosome-lysosome
fusion observed following a shift to leucine-free medium was not solely
mediated by the inhibition of mTOR.
Furthermore, filipin staining indicated that rapamycin neither promoted
the accumulation of cholesterol, nor altered the distribution of cholesterol in
U18666A-treated cultures (Fig. 21A,B).
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Figure 20: Rapamycin treatment results in efficient inhibition of the mTOR
pathway, but does not lead to enhanced autophagosome degradation.
1c1c7 cultures were left untreated or exposed to 1 µM U18666A for 48 h prior
to being treated with 30 nM rapamycin (Rap) and harvested 2, 3 and 5 h later
for analyses of LC3, p-p70 S6K, p70 S6K and β-actin. Each lane contained 25
µg of protein.
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Figure 21. Autophagosome clearance is not mTOR-dependent (A) GFPLC3 expressing and non-expressing 1c1c7 cultures were treated with 1 µM
U18666A (UA) or left untreated for 48 h prior to the addition of 30 nM
rapamycine (Rap) for 2, 4, 6 or 8 h. At the time of harvest, cultures were fixed
and stained with filipin (non-GFP-LC3 expressing) or immunostained with antiLAMP1 (GFP-LC3 expressing). Colocalization of GFP-LC3 (green) with LAMP1
(red) in Z plane sections is indicated by yellow/orange punctate spots. White
bar in panel A, top rows, represents 10 microns and the white bar in the lower
rows represents 20 microns (B) Per cell quantification of filipin fluorescence in
cultures depicted in panel A. Data represent means ± SD of 17-26 cells per
treatment group taken from multiple independent fields of cells. *Significantly
greater than nontreated control, P<0.05.
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2.3.9 CAD treatment increases autophagosome half-life
Autophagosomes accumulate as a consequence of an imbalance in their
rates of synthesis and degradation. Pacheco et al. (2007) showed that in NPC
fibroblasts

autophagosome

accumulation

was

due

to

increased

autophagosome synthesis, mediated by enhanced levels of beclin-1. Yet
Pacheco

et

al.

(2007)

did

not

adequately

analyze

the

effects

on

autophagosome degradation. As shown in Fig. 14, ‘autophagic flux’ studies
indicate that during U18666A treatment autophagosome synthesis and
degradation continues to occur simultaneously. Therefore, in order to properly
examine U18666A-mediated effects on autophagosome degradation it is
necessary to inhibit autophagosome synthesis. For this, I took advantage of the
fact that U18666A-mediated autophagy is induced via beclin-1 which is part of
the canonical autophagic pathway (Pacheco et al., 2007). 3-MA is an effective
inhibitor of PI3K and can be used to inhibit autophagosome synthesis through
the canonical pathway (Wu et al., 2010).
To study autophagosome turnover I utilized 3-MA as a tool to inhibit
autophagosome synthesis. Autophagosome formation induced by treatment
with rapamycin, U18666A, or shifting to leucine-free medium was inhibited by
cotreatment of GFP-LC3 expressing 1c1c7 cultures with 5 mM 3-MA (Fig. 22).
Five mM 3-MA was as effective as 10 mM (unpublished data).
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Fig. 22: 3-MA-treatment prevents autophagosome formation in U18666A,
rapamycin, or leucine-starved 1c1c7 cells. Cultures of 1c1c7 cells stably
expressing a GFP-LC3 fusion protein were treated with the 1 µM U18666A for
24 h, 30 µM rapamycin for 6 h, or shifted to leucine-free medium for 6 h alone
or in combination with 5 mM 3-MA prior to being fixed and imaged. White bar
represents 20 microns.
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When added to cultures that had undergone a shift to leucine-free

medium 3 h earlier, 3-MA caused a very rapid loss of preformed
autophagosomes

(Fig.

23A,

B

and

G).

The

calculated

half-life

of

autophagosomes in cultures shifted to leucine-free medium was ~0.7 h (Fig.
23G). The half-life of autophagosomes in rapamycin-treated cultures (i.e., ~2.5
h) was slower than that measured in cultures shifted to leucine-free medium
(Fig. 23C and G), but significantly faster than autophagosome turnover in
cultures treated with the CADs clozapine or U18666A (Fig. 23D, E and G).
Indeed, autophagosome turnover was minimally 10-fold slower in CAD-treated
cultures. As expected, based upon the LAMP1 and GFP-LC3 colocalization
analyses presented in Figure 19A, the shifting of U18666A treated cultures to
leucine-free medium induced the clearance of pre-existing autophagosomes
(Fig. 23F, G). The true rate of this clearance became apparent if 3-MA was
added immediately before the shift to leucine-free medium. With such
conditions U18666A-generated autophagosome half-life was reduced from ~29
h to ~2.6 h (Fig. 23G). To my knowledge, this is the first examination of
autophagosome

degradation

in

CAD-treated

cultures.

CAD

treatment

dramatically lengthens autophagosome half-life. This could explain why
autophagosome

degradation

does

not

keep

pace

with

increased

autophagosome synthesis and why autophagosomes accumulate in CADtreated cultures.
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Figure 23: Rates of autophagosome clearance. In the following experiments
cultures of GFP-LC3 expressing 1c1c7 cells underwent different treatments
prior to the addition of 3-methyladenine (3-MA, 5 mM final) to half of the
cultures. Cultures were subsequently harvested at various times after 3-MA
addition (noted as time 0 in the figures) for per cell analyses of autophagosome
content. (A) Cultures were shifted to leucine-free medium (starvation, ST) for 3h
prior to the addition of 3-MA and subsequent fixation for visualization of
autophagosomes by fluorescence microscopy. White bar represents 20
microns. (B) Per cell quantification of autophagosomes in cultures depicted in
panel A. Data represent means ± SD of 23-43 cells per treatment group. (C)
Cultures were treated with 30 nM rapamycin for 3 h prior to the addition of 3MA, and subsequent harvesting for per cell analyses of autophagosome
content. Data represent means ± SD of 20-37 cells per treatment group. (D,E)
Cultures were treated with 10 µM clozapine (D) or 1 µM U18666A (E) for 36 h
prior to the addition 3-MA and subsequent harvesting at varied times for per cell
analyses of autophagosome content. Data represent means ± SD of 23-38 and
20-37 cells for clozapine or U18666A treatment groups, respectively. (F)
Cultures were pretreated with 1 µM U18666A for 36 h prior to the addition of 3MA to the indicated set of cultures. Immediately thereafter all cultures were
shifted to leucine-free medium and subsequently harvested at various times
thereafter for per cell analyses of autophagosome content. Data represent
means ± SD of 20-37 cells per treatment group. Panels B,C,E and F are
representative of 3-4 individual experiments. (G) Autophagosome half-lifes
calculated from the types of studies presented in panels A-F using best-fit
values obtained with GraphPad Prism Software. Data represent means ± SD of
3-4 experiments. *Significantly greater than corresponding counterpart treated
with 3-MA, P<0.05. †Significantly greater than starvation + 3-MA, rapamycin +
3-MA, and U18666A + ST + 3-MA treatment groups, P<0.05.
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2.4 DISCUSSION
The current study was prompted by the observation that there is a strong
association between the accumulation of intracellular late endosomal/lysosomal
non-esterified cholesterol within LSDs or with drug treatment and alterations in
the autophagic process (Liao et al., 2007, Pacheco et al., 2007, Cenedella,
2009, Ishibashi et al., 2009). Multiple studies suggested a link between
lysosomal non-esterified cholesterol and autophagosome accumulation within
NPC and other LSDs (Table 1). From these previous reports, I hypothesized
that autophagosome accumulation is a consequence of lysosomal nonesterified cholesterol accumulation. To test this hypothesis, I utilized U18666A
to induce an NPC phenocopy. I observed that U18666A-treatment led to the
parallel accumulation of autophagosomes and non-esterified lysosomal
cholesterol. I also demonstrated that with the time-dependent depletion of
lysosomal non-esterified cholesterol upon U18666A removal from the medium,
there was a concurrent clearance of autophagosomes. Notably, two additional
CADs, clozapine and imipramine, also induced the same coordinated increase
in autophagosome and lysosomal non-esterified sterol content. These initial
studies appeared to support my hypothesis. However, the shifting of U18666Atreated cultures to a leucine-starvation medium triggered autophagosomelysosome fusion without coordinated reductions in lysosomal non-esterified
cholesterol content. This suggests that starvation-induced autophagosome
clearance is not affected by lysosomal non-esterified cholesterol accumulation
and therefore does not support a cause-and-effect relationship between
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autophagosome

accumulation

and

lysosomal

non-esterified

cholesterol

accumulation. Furthermore, autophagic flux studies and autophagosome halflife studies demonstrate autophagosome degradation is occurring, yet at a rate
that does not keep pace with autophagosome synthesis. These studies suggest
that CAD-induced autophagosome accumulation is the result of an imbalance
between autophagosome synthesis and degradation.
Table 2: Lysosomal storage diseases with coordinate
autophagosomes and non-esterified cholesterol content.

increases

in

	
  
	
  
Autophagy is described as an efficient process existing in equilibrium
between autophagosome synthesis and degradation (Boland et al., 2008; Chu
et al., 2006). CAD treatment resulted in an increase in autophagosome
synthesis and although flux through the system appeared to continue, the rate
of autophagosome degradation did not match that of synthesis. These
observations are in agreement with reports made by Pacheco et al. (2007), in

	
  

	
  

87	
  

which the autophagic pathway within NPC cells remains functional and
accumulation of autophagosomes was due to increased synthesis without
compensatory degradation. They demonstrated that NPC1 deficiency results in
an increase in beclin-1 expression, which promotes increased autophagosome
synthesis. Yet, Pacheco et al. (2007) provided no further analysis on the
specific effects of autophagosome degradation in NPC1 deficient models. In the
current study, 3-MA was utilized as a tool to facilitate the study of
autophagosome degradation rates in control and U18666A-treated cells. The 3MA

protocol

utilized

in

this

study

successfully

isolated

existing

autophagosomes from autophagosomes that were continually being generated
due to enhanced synthesis. This allowed for the observation and measurement
of the half-life of existing autophagosomes. For the first time, I demonstrate
that autophagosome accumulation induced by CAD-treatment was due to
increased synthesis coupled with a very slow rate of degradation. Specifically,
autophagosomes generated by shifting to leucine-free medium, or by treatment
with rapamycin, U18666A or clozapine had half-lives of ~0.7, 2.5, 29 and 26 h,
respectively. Interestingly, autophagosome half-life in CAD-treated cultures was
≥ 10-fold longer than that observed in the rapamycin-treated or leucine-starved
cultures. This finding raises the question as to what is causing extended
autophagosome half-life in CAD-treated cells. There are two possible
explanations for impaired autophagosome degradation: (1) a decrease in
autophagosome-lysosome

fusion

or

(2)

suppressed

autophagosome to the lysosome due to trafficking defects.

	
  

delivery

of

the

	
  

88	
  
Excess membrane cholesterol content can have affects on membrane

fluidity, lipid organization and microdomain composition (Pike, 2004; Helms and
Zurzolo, 2004). Studies have demonstrated that excess non-esterified
cholesterol accumulation resulted in inhibition of endosomal fusion and
impaired clearance of [14C]sucrose through the endosomal system (Zhang et
al., 2001 and Neufeld et al., 1999, respectively). Furthermore, there is evidence
that alterations in lysosomal non-esterified cholesterol content can affect
autophagosome

fusion.

For

example,

removal

of

cholesterol

from

autophagosomes or endosomes/lysosomes suppressed their ability to fuse in in
vitro fusion assays (Koga et al., 2010). Alternatively, Fraldi et al. (2010)
reported that in mouse models of multiple sulfatase deficiency and
mucopolysaccharidosis type IIIA, accumulation of non-esterified sterols within
the lysosomal membrane restricted the SNARE (soluble N-ethylmaleimide
attachment protein (SNAP) receptor) mediated fusion of autophagosomes and
lysosomes. Phagosome-lysosome fusion, a process somewhat analogous to
autophagosome-lysosome fusion, is also suppressed in both NPC and
U18666A-treated cultures (Lebrand et al., 2000).
Previously, Settembre et al. (2008) concluded that autophagosomelysosome fusion was blocked in LSD murine models due to autophagosome
accumulation, lack of colocalization of autophagosomes and lysosomes, and
the decreased ability to degrade exogenous protein aggregates. In the current
study, my results appear to agree with Settembre et al. due to very little
colocalization of LC3-positive punctate structures (i.e., autophagosomes) with
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LAMP1 positive structures (i.e. late endosomes/lysosomes). Yet, 3H-leucine
studies, flux assays, and 3-MA studies all demonstrate that there is still
degradation occurring through the autophagic pathway. Additionally, shifting
U18666A-treated cultures to leucine-free medium rapidly induced LC3 and
LAMP1 colocalization, and resulted in the subsequent loss of LC3-II without the
loss of non-esterified cholesterol/sterol content (Fig. 16 and 17). The ability to
enhance autophagosome-lysosome fusion in the presence of non-esterified
cholesterol laden lysosomes is in contrast with the findings of Fraldi et al.
(2010). Although, it is conceivable that reorganization of SNAREs may impair
fusion with some lysosomes, additional populations of lysosomes may exist that
are still capable of fusion events. This scenario is similar to one in which
populations of lysosomes that are involved with the selective uptake of proteins
in CMA (Cuervo et al., 1997). The studies discussed above suggest that it is
unlikely that the observed accumulation of U18666A-induced autophagosomes
is due to impaired autophagosome-lysosome fusion.
	
  

Excessive accumulation of non-esterified cholesterol can also impair

endosomal trafficking. For example, impaired trafficking is observed in NPC
models that exhibit slowed or inhibited late endosomal tubulovesicle movement
(Zhang et al., 2001). Rab proteins have also been found sequestered or
inactivated within cholesterol enriched late endosomes and lysosomes. Rab
GTPase proteins serve as mediators of endosomal trafficking and fusion (Jager
et al., 2004; Kimura et al., 2007). Several investigators have reported that Rab9
(Ganley and Pfeffer, 2006), Rab7 (Huynh et al., 2008; Lebrand et al., 2000),
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and Rab4 (Choudhury et al., 2004) are enriched in the cholesterol-enriched
membranes of U18666A-treated or NPC cells. The guanine nucleotide
dissociation inhibitor is unable to remove Rab proteins from the cholesterol
enriched membranes. This sequestering of Rab proteins to cholesterol rich
membranes presumably neutralizes their functions (Lebrand et al., 2000;
Choudhury et al., 2004). These tight associations are relevant to LSDs since
Rab4 mediates endosomal sorting of lipids to the cell surface (Choudhury et al.,
2004), Rab9 mediates cholesterol egress from late endosomes (Choudhury et
al, 2002; Walter et al., 2009), and Rab7 is required for phagosome-lysosome
and autophagosome-lysosome fusion (Gutierrez et al., 2004; Jager et al.,
2004). Over-expression of Rab7 and Rab9 has been shown to reduce
cholesterol accumulation in NPC cells, but there are currently no studies
indicating that this approach also induces autophagosome clearance
(Choudhury et al., 2004). Further studies are needed to examine the effect of
non-esterified cholesterol accumulation on autophagosome trafficking events.
The correlation between the kinetics of the accumulation of nonesterified cholesterol/sterols and autophagosomes initially suggested a causeand-effect relationship. Yet, based on the results obtained in this study,
lysosomal non-esterified cholesterol does not appear to inhibit autophagosome
clearance. Specifically, shifting U18666A-treated cultures to leucine-free
medium induced autophagosome-lysosome fusion without a significant change
in per cell lysosomal non-esterified cholesterol content (Fig. 17). Western blot
analysis also showed that a similar leucine-starvation protocol resulted in the
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decrease in LC3-II expression compared to U18666A-treatment alone,
suggesting enhanced autophagosome clearance (Fig. 16). Furthermore,
turnover of 3H-leucine labeled long-lived proteins continued to be cleared in
cultures treated with U18666A suggesting that the autophagy pathway was still
intact (Fig. 13). Lastly, U18666A- or clozapine-treated cultures, two conditions
known to induce accumulation of nonesterified cholesterol in lysosomes,
induced production of autophagosomes that continued to be degraded but at
rates dramatically slower than leucine-starvation or rapamycin-treatment (Fig.
23).

Taken

together,

autophagosomes

can

these
be

studies

cleared

by

suggest

that

non-esterified

U18666A-induced
cholesterol

laden

lysosomes. Therefore, accumulations of lysosomal non-esterified cholesterol do
not appear to be the cause of autophagosome accumulation. This, however,
does not rule out a “condition” induced by cholesterol accumulation within late
endosomes/lysosomes that would suppress autophagosome degradation or
trafficking under basal or QC conditions, not during starvation conditions.
Multiple investigators have identified specific intracellular components as being
involved in the cellular response to specific autophagy inducing stimuli. For
example, actin filaments are necessary in QC autophagy, but are not necessary
during starvation-induced autophagy (Lee et al., 2010). Microtubules become
hyperacetylated in response to starvation allowing for increased dyneinassisted transport towards the lysosome and this effect is specific to starvationinduced autophagy (Geeraert et al., 2010). In a recent study, both starvation
and rapamycin, a potent inhibitor of mTOR, were found to inhibit mTORC1, but
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only the starvation stimulus resulted in the repositioning of lysosomes and
fusion of lysosomes with autophagosomes (Korolchuk et al., 2011). This is in
agreement with the current study, as both rapamycin treatment and starvation
suppressed mTOR, but only the starvation stimulus was able to enhance
autophagosome-lysosome fusion.
Intracellular cholesterol accumulation occurs in several pathologies in
addition to the lysosomal storage diseases listed in Table 1. Lysosomal sterols
accumulate in cells derived from patients with cystic fibrosis (Gentzsch et al.,
2007), Pelizaeus-Merzbacher syndrome (Simons et al., 2002), and in mouse
models of Charcot Marie Toothe disease Type 1A (CMT1A) (Katona et al.,
2011). There are also reports of lysosomal sterol accumulation within human
breast, liver, and pancreatic cancers (Martin-Kleiner and Gall Troselj, 2010). An
understanding of the underlying mechanisms that mediates non-esterified
cholesterol accumulation may be beneficial to understanding other pathologies
in addition to LSDs.
In addition to the CADs utilized in this study, other members of the CAD
family have been found to induce non-esterified cholesterol accumulation in late
endosomes/lysosomes (Pameri et al., 1995; Tyteca et al., 2001; Suarez et al.,
2004; Reiners et al., 2011). This connection is significant, because CADs are
commonly used in medicine as estrogen receptor antagonists (Tamoxifen),
anti-arrythmics (amiodarone), anti-psychotics (clozapine), anti-depressants
(imipramine, amitriptyline, fluoxetine), and anti-bacterials (azithromycin).
Interestingly, these drugs have also been associated with the ability to induce
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autophagy (Morissette et al., 2009; Cloonan and Williams, 2011; Zschocke et
al., 2011; Gonzalez-Malerva et al., 2011).
In summary, the concurrent accumulation of non-esterfied cholesterol
and autophagosomes in response to U18666A treatment, and the subsequent
removal in a concurrent manner when the drug is omitted from the medium
suggest a link between autophagosome and non-esterified cholesterol
accumulation. In my study autophagosomes appear to accumulate because the
rate of autophagosome degradation is unable to keep pace with U18666Ainduced autophagome synthesis. Autophagosome degradation was only
increased when U18666A-treated cultures were shifted to leucine-free medium,
yet this phenomenon proved to be independent of mTOR. While leucinestarvation did enhance autophagosome clearance, there was no effect on late
endosome/lysosome filipin staining intensities. Instead, U18666A-induced tight
perinuclear staining patterns adopted a dispersed pattern in response to
leucine starvation. Alterations in lysosomal positioning in response to nutrient
starvation have previously been reported by Korolchuk et al. (2011) and might
explain this observation. Taken together, this body of work suggests that nonesterified cholesterol/sterol accumulation facilitates the development of a
condition that suppresses autophagosome trafficking to the lysosome for
degradation. These findings may reveal an unanticipated side effect of
commonly used therapeutics and are relevant to a number of diseases in which
accumulation of lysosomal non-esterified cholesterol occurs. The development
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of therapeutics designed to reverse the “condition” established by non-esterified
cholesterol/sterol accumulation may be a future treatment strategy.

	
  

	
  

95	
  
CHAPTER 3
HIGHLY FILAMENTOUS VIMENTIN IMPEDES AUTOPHAGOSOME
TRAFFICKING TO LYSOSOMES AND INDUCES THE NPC PHENOTYPE

3.1 INTRODUCTION
In the previous section, I demonstrate that CAD-treatment does not
appear to inhibit autophagosome-lysosome fusion and therefore, is not likely to
be the cause of autophagosome accumulation. Instead, I found that the half-life
of the autophagosome is dramatically extended in CAD-treated cultures (Fig.
23). Since fusion and degradation capabilities appear to still be intact within the
system, the next logical step was to explore the basis for deficiencies in
trafficking of the autopahgosome to the lysosome.
Autophagosomes are formed throughout the cell and move in the
direction of the centrosome where lysosomes are located. This movement is
mediated by the cytoskeletal network (Reggiori et al., 2005; Fass et al., 2006;
Kimura et al., 2008; Lee et al., 2010). Research during the last 20 years has
indicated that cytoskeletal networks play a substantial role throughout the
autophagy process and are conserved from yeast to mammalian cells (Reggiori
et al., 2005; Monastyrska et al., 2008; Lee et al., 2010). MT, actin and IFs have
all been shown to be involved in autophagosome formation (Blankson et al.,
1995; Fass et al., 2006; Kochl et al., 2006; He and Klionsky, 2007).
Additionally, the MT motor protein dynein has been shown to play a role in
autophagosome transport towards the MTOC (Kimura et al., 2005). Knockdown
and inhibitor studies demonstrate that dynein and MT dysfunction result in the
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build-up of autophagosomes and decrease autolysosome formation (Ravikumar
et al., 2005; Rubinsztein et al., 2005; Jahreiss et al., 2008). Both MT and actin
are implicated in the autophagosome-lysosome fusion process (Xie et al., 2010;
Lee et al., 2010).
Particular cytoskeletal elements appear to play more of a role in
response to some autophagy stimuli than in others (Fass et al., 2006; Lee et
al., 2010). For example, actin is necessary for efficient autophagosome
clearance during QC autophagy in which mis-folded proteins and damaged
organelles are removed by autophagy (Reggiori et al., 2005; Lee et al., 2010).
Alternatively, MTs are required for starvation-induced autophagosome
formation (Fass et al., 2006; Geeraert et al., 2010). Due to the limited
availability of IF inhibitors, there is limited knowledge of the role IF play in
autophagy.
Cytoskeletal abnormalities have been associated with a number of
degenerative diseases. In ALS patient brains, post-translational modification of
α-tubulin by nitration leads to neuronal cell death (Eiserich et al., 1999). IFs
are associated with aggresomes, which are commonly found in diseases such
as amyloidosis, ALS, HD, and PD. Transgenic murine models over-expressing
the IF α-internexin or exhibiting a mutation in the IF neurofiliament-M both
exhibit deficits in motor coordination and neurodegeneration (Ching et al., 1999;
Lavedan et al., 2002, respectively). Vimentin-null murine models also exhibit
neurodegenerative symptoms including impaired motor coordination and
Purkinje cell death (Colucci-Guyon et al., 1999).
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In the previous chapter I found that autophagosomes accumulated in

CAD-treated cultures because of increased autophagosome synthesis without
a compensatory increase in degradation. Leucine-starvation studies indicated
that autophagosome–lysosome fusion was not affected by lysosomal nonesterified

cholesterol

accumulation.

I

hypothesize

that

increased

autophagosome half-life is the result of a trafficking defect that prevents
efficient clearance of CAD-induced autophagosomes. In this chapter I examine
the relationship between the cytoskeleton and the NPC phenotype, which is
typified by accumulations of autophagosomes and non-esterified cholesterol in
late

endosomes/lysosomes.

I

performed

systematic

analyses

of

the

cytoskeleton and found that both actin and vimentin were altered in U18666Atreated cultures. Further investigation demonstrated that autophagosome
accumulation in U18666A-treated cultures correlated specifically with vimentin
being in a highly filamentous state. I further found that I could convert
filamentous vimentin into soluble vimentin by using TPA to activate protein
kinase C (PKC) and phosphorylate vimentin. Conversion of filamentous
vimentin

into

soluble

vimentin

was

accompanied

by

the

loss

of

autophagosomes and lysosomal non-esterified cholesterol. Conversely, I found
that I could promote lysosomal cholesterol and autophagosome accumulation,
and the conversion of soluble vimentin into filamentous vimentin, by inhibiting
PKC activity. Finally, I further show, for the first time, that activation of PKC and
disruption of filamentous vimentin in NPC fibroblasts promotes loss of
lysosomal cholesterol and the clearance of autophagosomes.
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3.2 MATERIALS AND METHODS
3.2.1 Chemicals
Chemicals listed in section 2.2.1 were used in the following studies in
addition to cytochalasin D, DMSO, 12-O-tetradecanoylphorbol-13-acetate
(TPA), bisindolylmaleimide 1 (Bis-1), and Triton X-100 that were all purchased
from Sigma (St. Louis, MO). Rhodamine-phalloidin was purchased from
Invitrogen (Carlsbad, CA).
3.2.2 Cell lines and culture conditions
Culture conditions for 1c1c7 murine hepatocyte cells or 1c1c7 cells
stably expressing a GFP-LC3 fusion protein are described in section 2.2.2.
Normal (GM 5629) and NPC (GM3123) fibroblast cell lines (a gift from S.
Terlecky, Wayne State University) were maintained in MEM (Gibco-BRL,
Carlsbad, CA) supplemented with 10% FBS (Hyclone, Logan, UT), 2 mM Lglutamine, and 100 units/mL penicillin and 100 mg/mL streptomycin (GibcoBRL, Carlsbad, CA) at 37oC in a humidified atmosphere consisting of 95% air
and 5% CO2.
3.2.3 Western blot analyses
Western blotting procedure and antibodies are described in section
2.2.3.
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3.2.4 Sterol detection
Detection of nonesterified cholesterol/sterols is described in section
2.2.5.
3.2.5 Actin detection with Phalloidin staining
Cultures were washed three times with PBS and fixed with 4%
paraformaldehyde/PBS (w/v) for 30 min at room temperature. After the
coverslips were washed three times with PBS the cells were permeabilized in
0.2% Triton/PBS (v/v) for 5 min. Non-specific binding sites were then blocked
using a 0.2% BSA/0.1% Triton/PBS solution for 30 min. Cells were then
incubated in a 1:500 dilution of rhodamine-phalloidin in a 0.1% Triton/PBS
solution for 1 h at room temperature. The coverslips were washed three times
with PBS and inverted onto glass slides with a drop of SlowFade solution and
sealed with acrylic nail polish. Phalloidin images were captured using a filter set
consisting of 546 nm excitation, 580 nm dichroic mirror, and 590 nm emission.
3.2.6 GFP-LC3 colocalization with LAMP1
Colocalization of GFP-LC3 with lysosomal LAMP1 was previously
described in section 2.2.7.
3.2.7 Visualization of GFP-LC3
Detection of GFP-LC3 fluorescence was previously described in section
2.2.8.
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3.2.8 Visualization of vimentin by fluorescence microscopy
Cultures were washed three times with PBS and fixed with 4%
paraformaldehyde/PBS (w/v) for 30 min at room temperature. Fixed cultures
were subsequently washed 3x with PBS/0.1% saponin, and incubated in
blocking buffer (5% BSA/PBS/0.1% saponin) for 1 h at 37oC to inhibit nonspecific immunoglobulin binding.

The coverslips were washed and then

incubated with 1:40 goat anti-human vimentin antibody (Sigma, St. Louis, MO)
in blocking buffer for 2 h at 37oC. The coverslips were washed followed by
incubation with 1:200 dilution of AlexaFluor 546 donkey anti-goat IgG
(Molecular Probes, Eugene, OR) in blocking buffer for 1 h at 37oC.

The

coverslips were again washed three times and inverted onto glass slides with a
drop of Slowfade solution (Molecular Probes, Eugene, OR) and sealed with
acrylic nail polish. AlexaFluor 546 fluorescence was captured using a filter set
consisting 546 nm excitation, 580 nm dichroic mirror, and 590 nm long pass
emission.
Alternatively, vimentin staining was detected using a 543 nm HeNe laser
on a Zeiss LSM-510 META NLO laser scanning confocal microscope. The
pinhole was set to 1 Airy unit. Images were captured in 1 µm z-stack slices.
Images were processed by either Image J or Volocity software (Waltham, MA).
All confocal imaging was performed at the Microscopy, Imaging and Cytometry
Resources Core at Wayne State University, School of Medicine.
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3.2.9 Colocalization of GFP-LC3 and Vimentin by Confocal Microscopy
In order to colocalize GFP-LC3 with vimentin, 1c1c7 cultures containing
the GFP-LC3 construct were processed as described in section 3.2.6. GFPLC3 and vimentin staining were detected using a 458/477/488/514 nm multiline
argon laser and a 543 nm HeNe laser on a Zeiss LSM-510 META NLO laser
scanning confocal microscope. Images were captured in 1 µm z-stack slices.
3.2.10 Autophagosome Clearance Protocol
Autophagosome clearance protocol is described in section 2.2.9.
Cultures were treated with 1 µM U18666A for 48 h prior to the addition of 5 mM
3-MA alone or in combination with 10 nM TPA.
3.2.11 Statistical Analysis
Data were analyzed by one-way ANOVA, Kruskal-Wallis test, one-way
ANOVA and Tukey’s Multiple Comparison post-hoc test, or two-way ANOVA
and Bonferroni post-hoc test (Prism 5, Graphpad Software, San Diego, CA).
Differences between/among groups were scored as statistically significant if P
<0.05.
3.3 RESULTS
3.3.1 Effects of U18666A on actin fibers
Recent studies have indicated that there are roles for both microtubules
and actin fibers in autophagy (Lee et al., 2010, Geeraert et al., 2010). The
findings that shifting U18666A-treated cultures to leucine-free medium
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enhanced autophagosome-lysosome fusion and the dispersion of cholesterol
enriched lysosomes suggested that U18666A might affect cytoskeletal
elements (Fig. 17). Immunofluorescence microscopy indicated that U18666A
had little effect on microtubules (Fig. 24). To examine F-actin I employed
rhodamine labeled phalloidin, a toxin that binds to F-actin that can be monitored
by fluorescence microscopy (Verderame et al., 1980). Staining with rhodaminephalloidin showed that a concentration of U18666A sufficient to enhance
autophagosome and lysosomal cholesterol/sterol accumulation dramatically
reduced the number of F-actin stress fibers (Fig. 25). Since leucine-starvation
was able to enhance autophagosome-lysosome fusion, I wanted to determine if
leucine starvation could also restore actin filaments. Although extended
culturing in leucine-free medium often results in the loss of actin stress fibers
(Tamm et al., 1992), no remarkable effect on stress fiber content occurred
within the first 6 h of shifting non-treated 1c1c7 cultures to leucine-free medium
(Fig. 25). However, such a shift initiated a restoration of the actin fiber network
in U18666A-treated cultures (Fig. 25). Partial recovery was obvious within 2 h
of shift, and became more pronounced with time.
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Figure 24: U18666A does not alter microtubules. 1c1c7 cultures were
treated with nothing or 1 µM U18666A for 48 h prior to being shifted to a
leucine-free medium. Cultures were fixed either just prior to, or 2, 4, 6, and 8 h
after medium shift. Cells were subsequently immunostained with anti-tubulin.
White bar represents 10 microns.
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Figure 25: Modulation of actin filaments with U18666A and leucinestarvation combination treatment. 1c1c7 cultures were treated with nothing
or 1 µM U18666A for 48 h prior to being shifted to a leucine-free medium.
Cultures were harvested for staining with rhodamine-conjugated phalloidin
either just prior to, or 2, 4, 6, and 8 h after medium shift. White bar represents
10 microns.
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To test if restoration of F-actin following leucine-starvation was indeed

the event leading to enhanced autophagosome-lysosome fusion, I employed
the F-actin inhibitor cytochalasin D (Cyt D). Cyt D prevents actin filament
assembly and also induces F-actin depolymerization (Casella et al., 1981).
Titration analyses indicated that 2.5 µM cytochalasin D (Cyt D) was the lowest
concentration at which reproducible, complete disruption of the actin stress
fiber network occurred in non-treated cultures (Fig. 26). Cyt D also caused
complete disruption of the actin stress fiber network in non-treated and
U18666A-treated cultures when shifted to leucine-free medium (Fig. 27).
Treatment with Cyt D alone for 6 h did not induce an accumulation of LC3-II
(Fig. 28). Co-treatment of U18666A-exposed cultures with Cyt D slightly
decreased LC3-II content. This effect may be explained by the reported
inhibitory effect of Cyt D on autophagosome formation (Aplin et al., 1992).
Nontreated cultures shifted to leucine-starvation medium (Starve) showed little
LC3-II expression due to the enhanced rate of autophagosome processing.
U18666A-treated cultures shifted to leucine starvation medium (U18666A +
Starve) showed a decrease in LC3-II expression when compared to U18666Atreated cultures (U18666A). Co-treatment of U18666A-exposed cultures with
Cyt D prior to shifting to leucine-free medium (U18666A + Cyt D + Starve)
exhibited LC3-II expression that was less than U18666A + Cyt D group, but
greater than U18666A + Starve group (Fig. 28). It appears that autophagosome
degradation is not inhibited by F-actin depolymerization during leucinestarvation, but degradation appears to be suppressed when compared to the
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U18666A + Starve group (Fig. 28). These results fail to give a clear distinction
as to F-actin’s role in starvation induced autophagosome clearance. To further
examine

F-actin’s

role

in

starvation-induced

autophagy

I

performed

colocalization analyses of LAMP1 and GFP-LC3 (Fig. 29). Such studies
confirmed that Cyt D pretreatment did not inhibit the rapid induction of
autophagosome-lysosome fusion that occurred following shift to leucine-free
medium (Fig. 29). Hence, although the leucine-starvation protocol stimulates
the redevelopment of actin stress fibers in U18666A cultures, such fibers do not
appear to play a significant role in starvation-induced autophagosomelysosome fusion.
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Figure 26: Cytochalasin D titration. 1c1c7 cultures were treated with
increasing concentration of cytochalasin D (Cyt D) over 48 h or left untreated.
Cultures were harvested for staining with rhodamine-conjugated phalloidin.
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Figure 27: Disruption of actin filaments with cytochalasin D treatment.
1c1c7 cultures were treated with nothing, 2.5 µM cytochalasin D (Cyt D) for 60
min, or 1 µM U18666A for 48 h ± cytochalasin D for the last 60 min prior to
being shifted to a leucine-free medium. Groups that had been pretreated with
Cyt D were shifted to a leucine-free medium that also contained the agent.
Cultures were harvested for staining with rhodamine-conjugated phalloidin
either just prior to, or 2, 4, and 6 h after medium shift. White bar represents 10
microns.
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Figure 28: Actin filament disruption reduces, but does not inhibit
autophagosome degradation under starvation conditions. 1c1c7 cultures
were treated with nothing, 2.5 µM cytochalasin D (Cyt D) for 60 min, or 1 µM
U18666A for 48 h ± cytochalasin D for the last 60 min prior to being shifted to a
leucine-free medium.
Cultures that had been pretreated with Cyt D were
shifted to a leucine-free medium that also contained the agent. Following
treatment, cultures were harvested for Western blot analyses of LC3 and βactin 5 h after medium shift. Each lane used 25 µg of protein lysate. Similar
data were obtained in an additional experiment.
	
  
	
  
	
  

	
  

	
  

110	
  

	
  
Figure 29: Actin filament disruption with cytochalasin D treatment does
not inhibit autophagosome-lysosome fusion under starvation conditions.
1c1c7 cultures that stably expressed GFP-LC3 were treated with nothing or 1
µM U18666A for 48 h before being shifted to leucine-free medium. An
additional set of non-treated and U18666A-treated cultures were treated with
2.5 µM cytochalasin D 60 min prior to being shifted to leucine-free medium.
Cultures were harvested immediately before, and at various times after the shift
for analyses of LAMP-1 and GFP-LC3 colocalization. White bar equals 10
microns.
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3.3.2 Effects of U18666A on vimentin
Walter et al. (2009) recently reported a causative relationship between
highly filamentous vimentin networks and late endosome/lysosome cholesterol
accumulation in NPC cells. They found that NPC fibroblasts displayed highly
filamentous and disorganized vimentin staining patterns. In NPC fibroblasts,
vimentin was restricted to a filamentous state due to hypophosphorylation.
Furthermore, Rab9 was found to be associated with vimentin filaments in cell
fractions and fluorescent colocalization studies, which suggested that Rab9
was entrapped within the highly filamentous vimentin network. Rab9 happens
to be necessary for non-esterified cholesterol egress from late endosomes and
lysosomes, and entrapment of Rab9 resulted in late endosome/lysosome nonesterified cholesterol accumulation (Walter et al., 2009). Walter et al. (2009)
also found that activation of PKC by treatment with phorbol esters increased
soluble vimentin and promoted cholesterol egress from the lysosomes. Of
particular relevance to my project, Walter et al. (2009) also reported that
U18666A treatment led to the same decrease in soluble vimentin as seen in
NPC fibroblasts. This prompted me to explore whether highly filamentous
vimentin could also sequester autophagosomes, and restrict their movement
toward the lysosome for degradation. Furthermore, if highly filamentous
vimentin networks within the cell restrict trafficking of both autophagosomes to
lysosomes and the egress of lysosomal non-esterified cholesterol, this
phenomenon could be the underlying mechanism of the NPC phenotype.
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Since treatment with U18666A mimics the NPC phenotype, I first wanted

to determine whether U18666A treatment also led to alterations in vimentin.
Fluorescene microscopy analysis showed that vimentin immunostaining in
nontreated wild-type fibroblasts displayed a diffuse pattern with thin filaments.
This was in contrast to the prominent filaments that appeared to extend
throughout the cytoplasm in NPC fibroblasts. Similarly, wild-type fibroblasts
treated with 1µM U18666A for 48 h also displayed prominent filaments that
extended throughout the cytoplasm of the cell. This suggests that treatment
with U18666A induces alterations in vimentin that appear to mimic those
observed in NPC fibroblasts (Fig. 30).
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Figure	
   30:	
   U18666A-‐treatment	
   of	
   wild-‐type	
   human	
   fibroblasts	
   results	
   in	
   a	
  
highly	
  fibrous	
  vimentin	
  characteristic	
  similar	
  to	
  fibroblasts	
  of	
  NPC	
  patients.	
  
Wild-‐type	
  human	
  fibrolasts	
  (WT),	
  fibroblasts	
  obtained	
  from	
  NPC	
  patients,	
  or	
  WT	
  
fibroblasts	
   treated	
   with	
   U18666A	
   for	
   48	
   h	
   were	
   fixed	
   and	
   immunostained	
   with	
  
anti-‐vimentin	
   antibody.	
   White	
   bar	
   represents	
   20	
   microns.	
   Insets	
   are	
   magnified	
  
images	
  of	
  the	
  area	
  designated	
  by	
  the	
  white	
  box.	
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3.3.3 PKC inhibition modulates vimentin filament/soluble status and
induces the NPC phenotype
The phosphorylation status of vimentin regulates vimentin filament
assembly and disassembly (Eriksson et al., 2004). Phosphorylation of vimentin
filaments results in disassembly into monomers and dephosphorylation of
vimentin monomers promotes filament assembly (Inagaki et al., 1997). Protein
kinase C (PKC) governs this process. Inhibiting PKC activation prevents
vimentin monomer phosphorylation and promotes vimentin filament formation
(Ivaska et al., 2005).
Bis-1 (bisindolylmaleimide 1) is a broad-spectrum inhibitor of PKC
(Toullec et al., 1991). In essence, Bis-1 treatment should inhibit PKC and
prevent phosphorylation of vimentin monomers restricting it to a filamentous
state. In nontreated 1c1c7 cultures vimentin immunostaining revealed patterns
that appeared to resemble sharp edges and were mainly in the periphery of the
cell. With Bis-1 treatment over time, vimentin appeared to form an increasingly
diffuse filament network that crisscrossed throughout the cytoplasm of the cell
(Fig. 31). Notable changes in vimentin filament staining patterns appeared to
become visible within 48 h of Bis-1 treatment and continued with time. This
study is in agreement with Walter et al. (2009) and demonstrates that inhibition
of PKC activity results in the same increase in filamentous vimentin as seen in
NPC and U18666A-treated fibroblasts (Fig. 30). Filipin staining anaylsis by
fluorescent microscopy revealed that PKC inhibition by Bis-1 treatment also led
to a time-dependent increase in filipin staining intensity, which most likely
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represents an accumulation of lysosomal non-esterified cholesterol/sterol (Fig.
32A and B). Interestingly, the kinetics of non-esterified cholesterol accumulation
roughly paralleled the kinetics of increased vimentin filament complexity
(compare Fig. 31 and Fig. 32). According to Walter et al. (2009) this similarity is
likely due to Rab9 entrapment within highly filamentous vimentin, which would
prevent the egress of non-esterified cholesterol from late endosomes.
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Figure 31: PKC inhibition modulates vimentin filament/soluble status in
1c1c7 cells. 1c1c7 cultures were treated with 1 µM bisindolylmaleimide 1 (Bis1) for 24 - 72 h prior to being fixed and immunostained with anti-vimentin.
Images were captured with either a confocal microscope using a 100x oil lens
(top row) or a fluorescent light microscope using a 40x oil lens (bottom row).
The white bar in the top row represents 10 microns and the white bar in the
bottom row represents 20 microns.	
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Figure 32: PKC inhibition results in time-dependent non-esterified
cholesterol accumulation in 1c1c7 cells. (A) 1c1c7 cultures were treated
with 1 µM bisindolylmaleimide 1 (Bis-1) for 24 - 72 h prior to being fixed and
stained with filipin. Images were captured using a 10 ms fixed exposure. (B)
Per cell quantification of filipin fluorescence in cultures depicted in panel A
using a fixed exposure period. Data represent means ± SD of 35-56 cells per
treatment group taken from multiple independent fields of cells. *Significantly
greater than the non-treated group, P<0.05.
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To determine if increased vimentin filament complexity also correlated to

autophagosome accumulation, 1c1c7 cultures stably expressing GFP-LC3
were subject to Bis-1 treatment over time (Fig. 33A and B). Bis-1 treatment
resulted in the coalescence of GFP-L3 into punctate spots that increased in
number over time. Bis-1-induced autophagosome accumulation was confirmed
by LC3-II Western blot analysis of non-GFP-LC3 containing 1c1c7 cultures
(Fig. 33C). This autophagosome accumulation is reminiscent of that induced by
U18666A-treatment (Fig. 9) and also occurs in NPC fibroblasts (Pacheco et al.,
2007).

Furthermore,

autophagosome

it

appears

accumulation,

that

the

lysosomal

kinetics

of

non-esterified

Bis-1-induced
cholesterol

accumulation, and vimentin filament formation, all paralleled one another, thus
suggesting a correlation between the three phenomena.
Previously,

U18666A-induced

autophagosome

accumulation

was

associated with little colocalization of GFP-LC3 and LAMP1-positive punctate
spots and this was later attributed to a prolonged autophagosome half-life (Fig.
12 and Fig. 23). To determine if Bis-1-induced autophagosome accumulation
was also associated with a decrease in autophagosome-lysosome fusion, I
monitored GFP-LC3 and LAMP1 localization over time. Within 48 h, yellow and
orange punctate spots that represent autophagosome-lysosome fusion
decreased in number compared to 24 h (Fig. 34). This suggests that PKC
inhibition by Bis-1 treatment decreases autophagosome-lysosome fusion
events with time. It is conceivable that like U18666A treatment, PKC inhibition
by Bis-1 treatment may also prolong autophagosome half-life.
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Figure 33: PKC inhibition results in time-dependent autophagosome
accumulation in 1c1c7 cells. (A) Cultures of 1c1c7 cells stably expressing a
GFP-LC3 fusion protein were treated with 1 µM bisindolylmaleimide 1 (Bis-1)
for 24-72 h prior to being fixed and imaged. (B) Per cell quantification of
autophagosomes in cultures depicted in panel A. Data represent means ± SD
of 10-59 cells per treatment group. *Significantly greater than non-treated
cultures, P<0.05. (C) Non GFP-expressing 1c1c7 cultures were treated with 1
µM Bis-1 for 2-36 h before being harvested and processed for Western blot
analyses of LC3. Each lane contained 25 µg of protein lysate. Similar results
were obtained in a second independent experiment.
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Figure 34: PKC inhibition results in autophagosomes that do not readily
fuse with lysosomes in 1c1c7 cells. 1c1c7 GFP-LC3 expressing cultures
were treated with 1 µM bisindolylmaleimide 1 (Bis-1) for 24-72 h or left
untreated. At the time of harvest cultures were fixed and immunostained with
anti-LAMP1. Colocalization of GFP-LC3 (green) with LAMP1 (red) in Z plane
sections is indicated by yellow/orange punctate spots. White bar represents 10
microns.
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3.3.4 PKC activation modulates vimentin filament/soluble status and
reverses the NPC phenotype
Bis-1 and U18666A induce a highly filamentous vimentin staining
pattern that appears to correlate with autophagosome accumulation and the
increase in lysosomal non-esterified cholesterol content (Fig. 31, 32, and 33).
Treatment of cell cultures with Bis-1 inhibited GFP-LC3 and LAMP1
colocalization and further suggests that highly filamentous vimentin prevents
efficient autophagosome clearance (Fig. 34). As a compliment to these earlier
studies, I then wanted to determine if promoting the disassembly of U18666Ainduced diffuse vimentin filament networks could clear autophagosome and
non-esterified cholesterol accumulations. To do this I utilized the phorbol ester
12-O-tetradecanoylphorbol-13-acetate	
   (TPA), a broad PKC activator, to
promote vimentin filament disassembly in U18666A-treated cultures (Yang et
al., 2002). Treatment of 1c1c7 cultures with 1 µM U18666A for 48 h shifted
vimentin immunostaining from mainly staining the edges of control cells to a
diffuse filament network. Activation of PKC with the addition TPA to U18666Atreated cultures appeared to promote vimentin redistribution to a pattern that
resembled that of control cells within 24 h (Fig. 35). To determine if PKC
activation also led to a decrease in U18666A-induced non-esterified cholesterol
accumulation, a similar protocol was performed and cultures were stained with
filipin to detect non-esterified cholesterol. U18666A-induced non-esterified
cholesterol accumulation was also diminished over time with TPA treatment
(Fig. 36A and B). Filipin staining intensity was significantly reduced within 24 h
of adding TPA to U18666A-treated cultures (Fig. 36B). These studies suggest
that activation of PKC by TPA can both reverse U18666A-induced diffuse
vimentin filament networks and non-esterified cholesterol accumulation. The
two phenomena appear to roughly follow similar kinetics and this may suggest
that these processes may be closely related. These findings are in agreement
with Walter et al. (2009) and further support that vimentin filament networks can
entrap proteins such as Rab9 that are needed for proper trafficking of nonesterified cholesterol through the endosomal system.
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Figure 35: PKC activation mediates vimentin filament dissociation in
U18666A-treated 1c1c7 cells. 1c1c7 cultures were treated with 1 µM
U18666A or left untreated for 48 h prior to the addition of 10 nM 12-Otetradecanoylphorbol-13-acetate	
   (TPA) or DMSO (Control) for 6, 18 or 24 h
prior to being fixed and immunostained with anti-vimentin. Images were
captured with either a confocal microscope using a 100x oil lens (top 2 rows) or
a fluorescence light microscope using a 40x oil lens (bottom 3 rows). The white
bar in the top set represents 10 microns and the white bar in the bottom set
represents 20 microns.
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Figure 36: PKC activation induces non-esterified cholesterol clearance in
U18666A-treated 1c1c7 cells. (A) 1c1c7 cultures were treated with 1 µM
U18666A or left untreated for 48 h prior to the addition of 10 nM 12-Otetradecanoylphorbol-13-acetate	
  (TPA) or DMSO (Control) for 6, 18, 24 or 48 h
prior to being fixed and stained with filipin. Images were captured using a 10 ms
fixed exposure. White bar represents 20 microns. (B) Per cell quantification of
filipin fluorescence in cultures depicted in panel A using a fixed exposure
period. Data represent means ± SD of 20-57 cells per treatment group taken
from multiple independent fields of cells. *Significantly greater than the nontreated and TPA-treated groups, P<0.05.
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Next, I wanted to determine if highly filamentous vimentin may also

sequester U18666A-induced autophagosomes and thus prevent proper
trafficking and clearance. To this end, I administered TPA to U18666A-treated
1c1c7 GFP-LC3 cultures in order to promote disassembly of filamentous
vimentin and observe its effects on autophagosome accumulation. U18666A
treatment for 48 h led to significant accumulations of GFP-LC3 punctate spots.
With the addition of TPA to U18666A treated cultures, autophagosome
numbers were reduced within 2 h and continued to decrease with passing time
(Fig. 37). U18666A-induced autophagosomes were readily cleared within 8 h of
TPA treatment (Fig. 37). TPA mediated clearance of U18666A-induced
autophagosomes was confirmed by Western blot analysis of LC3 in 1c1c7
cultures (Fig. 38). A decrease in LC3-II expression occurred within 6 h and
continued to decrease with time. At 8 h, LC3-II expression in U18666A + TPA
cultures were similar to that of control cultures. This suggests that PKC
activation mediated by TPA treatment of U18666A-treated cultures results in
enhanced autophagosome clearance.
Previously, autophagosome clearance in U18666A-treated cultures was
enhanced by shifting to leucine starvation media and resulted in the shortening
of autophagosome half-life (Fig. 23). To determine if PKC activation by TPA
treatment led to a similar alteration in autophagosome half-life, I performed an
autophagosome clearance protocol in U18666A treated cultures subsequently
treated with TPA. TPA mediated enhanced clearance of U18666A-induced
autophagosomes appeared to be due to increased autophagosome turnover.
	
  

	
  

125	
  

Indeed, autophagosome half-life was reduced approximately 7-fold (~29 h to
~3.9 h) in TPA + U18666A treated cultures (Fig. 39). Colocalization studies of
GFP-LC3 and LAMP1 confirmed the occurrence of TPA-mediated enhanced
autophagosome

clearance

in

U18666A

treated

cultures,

which

was

demonstrated by increased autophagosome-lysosome colocalization. Within 6
h of TPA addition, yellow and orange puncate spots were increased in number
compared to cultures treated with U18666A alone. By 24 h of TPA treatment,
U18666A-induced autophagosomes appeared to be mostly cleared with some
yellow punctate spots still visible. These studies suggest that PKC activation by
TPA

treatment

may

promote

the

clearance

of

U18666A-induced

autophagosomes. The evidence that PKC activation promoted vimentin
filament dissociation, decreased non-esterified cholesterol accumulations and
enhanced the clearance of autophagosomes suggests that these phenomena
could be related. Yet, it is important to acknowledge that clearance of
autophagosomes appeared to occur much sooner (within 2 h) than significant
decreases in non-esterified cholesterol and the reduction of diffuse vimentin
filament networks (within 24 h). This could potentially be explained by
differential effects on trafficking mechanisms unique to autophagosomes and
non-esterified cholesterol in relation to vimentin. This idea is explained in detail
in the ‘Discussion’ section of this chapter.
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Figure 37: PKC activation induces autophagosome clearance in U18666Atreated 1c1c7 cells. (A) 1c1c7 cells stably expressing a GFP-LC3 fusion
protein were treated with 1 µM U18666A (UA) or left untreated for 48 h prior to
the addition of 10 nM 12-O-tetradecanoylphorbol-13-acetate	
   (TPA) or DMSO
(Control) for 2, 4, 6 and 8 h prior to being fixed. White bar represents 20
microns. (B) Per cell quantification of autophagosomes in cultures depicted in
panel A. Data represent means ± SD of 25-32 cells per treatment group taken
from multiple independent fields of cells. *Significantly greater than the nontreated and TPA-treated groups, P<0.05.
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Figure 38: PKC activation lowers LC3-II in U18666A-treated 1c1c7
cultures. 1c1c7 cultures were treated with 1 µM U18666A (UA) or left
untreated for 48 h prior to the addition of 10 nM 12-O-tetradecanoylphorbol-13acetate	
   (TPA) or DMSO (Control) for 6 and 8 h prior to being harvested and
processed for Western blot analyses of LC3 and β-actin. Each lane contained
25 µg of protein lysate. Numbers indicate quantification of Western blot
analysis and were calculated by normalizing LC3-II expression to actin
expression. Control values were set as 1 and subsequent values were
compared to the corresponding control value.
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Figure 39: PKC activation leads to enhanced rate of autophagosome
clearance in U18666A-treated 1c1c7 cells. (A) 1c1c7 cells stably expressing
a GFP-LC3 fusion protein were treated with 1 µM U18666A (UA) for 48 h prior
to the addition of 5 mM 3-MA (final concentration) alone or in combination with
10 nM 12-O-tetradecanoylphorbol-13-acetate	
  (TPA) (noted as time 0). Cultures
were fixed and imaged at various times after 3-MA addition. White bar
represents 20 microns. (B) Per cell quantification of autophagosome content in
cultures depicted in panel A. Data represent means ± SD of 8-22 cells per
treatment group. Autophagosome half-lifes calculated using best-fit values
obtained with Graphpad Prism Software. *Statistically greater than UA+TPA+3MA treatment counterpart, P<0.05.
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Figure 40: PKC activation leads to enhanced autophagosome-lysosome
fusion and autophagosome clearance in U18666A-treated 1c1c7 cells.
1c1c7 cells stably expressing a GFP-LC3 fusion protein were treated with 1 µM
U18666A or left untreated for 48 h prior to the addition of 10 nM 12-Otetradecanoylphorbol-13-acetate	
  (TPA) or DMSO (Control) for 6 or 24 h prior to
being fixed and immunostained with anti-LAMP1. Colocalization of GFP-LC3
(green) with LAMP1 (red) in Z plane sections is indicated by yellow/orange
punctate spots. White bar in panel represents 10 microns.
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In the studies presented in figures 35-40, PKC activation converted

filamentous vimentin to a more soluble state in U18666A-treated cells and also
appeared to reverse two characteristics of the NPC phenotype, namely
lysosomal non-esterified cholesterol and autophagosome accumulation.
Therefore, I wanted to determine if PKC activation could also promote vimentin
filament dissociation and ultimately reverse the NPC phenotype in fibroblasts
derived from NPC patients. First, to monitor the effects of TPA treatment on
vimentin, wild-type human fibroblasts and NPC fibroblasts were treated with 10
nM or 40 nM TPA over 24 h. Treatment with 10 nM TPA had little to no effect
on wild-type fibroblasts, but produced noticeable alterations in vimentin
immunostaining patterns when treating with 40 nM TPA over 24 h (Fig. 41). In
nontreated NPC fibroblasts, vimentin immunostaining revealed prominent
filaments that extended throughout the cell, whereas NPC fibroblasts treated
with 40 nM of TPA for 24 h revealed diffuse vimentin staining with only fine
filaments visiable. This staining pattern appeared to be similar to that seen in
wild-type fibroblasts.
Then, NPC fibroblasts were subject to a similar TPA treatment protocol
but stained with filipin. All NPC cultures had non-esterified cholesterol contents
that were greater than their normal fibroblast counterparts, yet TPA treatment
resulted in a decrease in filipin staining intensity that appeared to be
concentration- and time-dependent (Fig. 42A and B). NPC fibroblasts treated
with either 10 nM or 40 nM TPA for 48 h resulted in significant decreases in
filipin staining intensity compared to nontreated NPC fibroblasts (Fig. 42B). This
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suggests that activation of PKC with TPA can successfully lower non-esterfied
cholesterol content in NPC fibroblasts (Fig. 42).
To determine if PKC activation by TPA treatment could also mediate
autophagosome clearance in NPC fibroblasts, I performed Western blot
analysis of LC3. LC3-II expression appeared to decrease in both a time- and
concentration-dependent manner (Fig. 43). Quantitation of LC3-II content
revealed that autophagosome content appeared to be reduced by half in NPC
fibroblasts treated with 40 nM TPA for 48 h (Fig. 43B). Taken together, PKC
activation by TPA treatment appeared to relieve the NPC phenotype within
NPC fibroblasts. In contrast to U18666A-treated cultures, vimentin filament
dissociation, decreases in non-esterified cholesterol content, and reduced LC3II expression roughly followed similar kinetics in NPC fibroblasts. Cell specific
effects on the rate of TPA-induced autophagosome clearance may explain this
difference. These findings further support a cause-and-effect relationship
between filamentous vimentin, autophagosome accumulation, and lysosomal
non-esterified cholesterol accumulation.

	
  

	
  

132	
  

	
  
Figure 41: PKC activation modulates vimentin filament/soluble status in
NPC fibroblasts. Wild-type human fibroblasts or NPC fibroblasts were treated
with 10 or 40 nM TPA or DMSO (Control) for 24 h or left untreated prior to
being fixed and immunostained with anti-vimentin.
White bar in panel
represents 20 microns.
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Figure 42: PKC activation reverses non-esterified cholesterol
accumulation in NPC fibroblasts. Wild-type human fibroblasts (WT) or NPC
fibroblasts (NPC) were treated with 10 or 40 nM TPA or DMSO (control) for 24
h, 48 h prior to being fixed and stained with filipin. White bar represents 20
microns. (A) Representative image at 24 h time point. (B) Per cell quantification
of filipin fluorescence using a fixed exposure period. Images were captured
using a 10 ms fixed exposure. Data represent means ± SD of 7-11 cells per
treatment group taken from multiple independent fields of cells. *Significantly
different than the corresponding NPC control, P<0.05.
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Figure 43: PKC activation lowers LC3-II in NPC fibroblasts. Wild-type
human fibroblasts (WT) or NPC fibroblasts (NPC) were treated with 10 nM
TPA, 40 nM TPA or DMSO (Control) for 24 h or 48 h prior to being harvested
and processed for Western blot analyses of LC3 and β-actin. (A)
Representative image at 24 h time point. Each lane contained 25 µg of protein
lysate. (B) Quantitative analysis of LC3-II levels relative to actin in 4
independent experiments. Control values were set as 1 and subsequent values
were compared to the corresponding control value.

	
  

	
  

135	
  
As mentoned before, Walter et al. (2009) proposed that Rab9 is

sequestered within the highly filamentous vimentin network of NPC fibroblasts,
thus preventing its role in cholesterol trafficking. Based on the correlation
between diffuse vimentin filament networks and autophagosome accumulation,
I wanted to determine if autophagosomes may also be sequested within highly
filamentous vimentin networks. To gain detailed imagery of autophagosome
and vimentin filament interaction, I performed a series of confocal colocalization
studies.

I

employed

U18666A

and

Bis-1

treatment

to

induce

both

autophagosome accumulation and diffuse filamentous vimentin networks.
These studies revealed a strong association between GFP-LC3 punctate spots
and vimentin filaments (Fig. 44A). In U18666A- and Bis-1-treated cultures,
autophagosomes appeared to be associated with vimentin filaments in a
manner that resembled “beads-on-a-string”. In contrast, leucine-starvation, a
method that induces a strong autophagy response, but does not alter vimentin
staining compared to nontreated cultures, did not exhibit autophagosomes that
associated with vimentin filaments (Fig. 44A). In order to further examine the
physical

interaction

between

autophagosomes

and

vimentin

filaments

throughout an entire U18666A-treated 1c1c7 GFP-LC3 cell, I performed 3D
assembly of z-stack confocal images. The 3D images revealed that a high
number of autophagosomes associate with vimentin filaments throughout the
entire cell. Furthermore, some autophagosomes appeared to be fully
sequestered within vimentin filaments (Fig. 44B). This interaction suggests that
autophagosomes are physically sequestered within highly filamentous vimentin
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and this interaction may impede efficient autophagosome trafficking to the
lysosome.
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Figure 44: Association of U18666A-induced autophagosomes with
vimentin filaments in 1c1c7 cells. (A) 1c1c7 cells stably expressing a GFPLC3 fusion protein were treated with 1 µM U18666A (UA) for 48 h, 1 µM
bisindolylmaleimide 1 (Bis-1) for 48, incubated in leucine-free medium for 6 h,
or left untreated before being fixed and immunostained with anti-vimentin.
White bar in panel A represents 10 microns. (B) 3D modeling of confocal zstack images taken of a 1c1c7 cell stably expressing a GFP-LC3 fusion protein
treated with 1 µM U18666A for 48 h prior to being fixed and immunostained
with anti-vimentin. White boxes in (A) and (B) indicate area of magnification.
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3.4 DISCUSSION
This study was prompted by observations made in the previous section
in which CAD-induced autophagosome accumulation was due to increases in
autophagosome synthesis and autophagosome half-life. Autophagosomelysosome fusion capabilities and degradation remained intact in CAD-treated
cells, but the decrease in autophagosome delivery to the lysosome resulted in
substantial accumulations of autophagosomes. From these observations I
hypothesized that the increase in CAD-induced autophagosome half-life was
due to suppressed trafficking to the lysosome. To test this hypothesis I
examined the effects of U18666A on the 3 types of cellular cytoskeleton, since
intracellular trafficking events are mainly orchestrated along cytoskeletal
networks, including the transport of the autophagosome to the lysosome.
Immunofluorescence microscopy indicated that U18666A-treatment had no
effect on microtubules, but did result in a loss of F-actin stress fibers (Fig. 26
and 27, respectively). Although shifting U18666A-treated cultures to starvation
medium did restore F-actin stress fibers over time (Fig. 27), it was not
necessary for starvation-induced autophagosome-lysosome fusion (Fig. 30 and
31). A recent study by Walter et al. (2009) demonstrated that vimentin is highly
filamentous in NPC fibroblasts and that entrapment of the trafficking component
Rab9 within vimentin filaments prevented retrograde trafficking of non-esterified
cholesterol. Here, for the first time, I show that autophagosomes also appear to
be sequestered within the highly filamentous vimentin of U18666A-treated
1c1c7 cultures. I also demonstrate a cause-and-effect relationship between
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highly filamentous vimentin and the “NPC phenotype” as defined by lysosomal
non-esterified cholesterol/sterol and autophagosome accumulation.
The CAD tamoxifen disrupts actin filaments and increases keratin IFs
(Verdugo-Gazdik et al., 2006; Sapino et al., 1986). Like tamoxifen, U18666Atreated 1c1c7 cells stained with rhodamine-phalloidin also displayed F-actin
disruption and increased vimentin IF staining, suggesting this phenomenon
could potentially be a general consequence of CADs. In the current study,
U18666A-treated cultures displayed F-actin reorganization following leucine
starvation (Fig. 29) that paralleled autophagosome-lysosome fusion and the
dispersion of filipin-stained puncta. Therefore, I examined whether F-actin
reorganization mediated autophagosome-lysosome fusion in U18666A-treated
cultures following leucine-starvation. Western blot analysis of Cyt D disruption
of F-actin delivered ambiguous results. LC3-II expression in the U18666A + Cyt
D + Starve treatment group was less than U18666A + Cyt D but greater than
U18666A + Starve treatment groups (Fig. 30). This suggests that actin may
have a minor effect on starvation-induced autophagy. This is contrary to what is
expected because actin is thought to be critical for “quality control” autophagy,
and not necessary for starvation-induced autophagy (Lee et al., 2010). In GFPLC3 and LAMP1 colocalization studies, yellow/orange puncta was observed in
U18666A + Cyt D cultures 6 h after shifting to leucine-starvation medium. This
suggests that autophagosome-lysosome fusion occurs in the absence of Factin (Fig. 31). Overall, F-actin did not appear to be critical for autophagosomelysosome fusion in U18666A-treated cultures.
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Although

speculative,

the

functional

interconnection

between

cytoskeletal elements may explain CAD-induced alterations in both F-actin and
vimentin. Correia et al. (1999) demonstrated that the actin bundling protein
fimbrin colocalized with vimentin. They further described that fimbrin binds
specifically to soluble vimentin and not to mature vimentin fibrils. It is hard to
say whether F-actin disruption is due to the U18666A-induced highly
filamentous state of vimentin, but this could explain the results obtained in my
study. Furthermore, tubulin was described by Geeraert et al. (2010) to be
required for starvation-induced autophagy. In my study, I did not observe CADinduced alterations in the microtubule network (Fig. 26), indicating that
U18666A treatment would not be expected to impede starvation-induced
autophagy.
In the current study treatment with U18666A induced a filamentous
vimentin staining pattern similar to that observed in NPC fibroblasts (Fig. 32).
This is in agreement with previous studies in which NPC fibroblasts and
U18666A-treated fibroblasts both exhibited an increase in filamentous vimentin
(Walter et al., 2009). Vimentin assembly and disassembly is mediated through
phosphorylation signals from PKC (Eriksson et al., 2004; Inagaki et al., 1987).
Treatment with the PKC inhibitor Bis-1 results in the hypophosphorylation of
vimentin that favors a highly filamentous state. Walter et al. (2009) showed that
highly filamentous vimentin was responsible for cholesterol accumulation in the
late endosomes and lysosomes of NPC fibroblasts. In agreement with Walter et
al. (2009), Bis-1-treatment also led to the accumulation of lysosomal non	
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esterified cholesterol that paralled the increase in filamentous vimentin
(compare Figs. 33 and 34).
The role of vimentin in cellular autophagosome-lysosome trafficking is a
developing hypothesis that has only previously been alluded to by Styers et al.,
(2005). In 2004, Styers et al. observed that detergent-insoluble vimentin
networks were highly associated with adaptor protein-3 (AP-3). AP-3 regulates
sorting from endosomes to lysosomes and, therefore, could potentially be
involved in autophagosome to lysosome trafficking (Peden et al., 2004). The
role of AP-3 in vimentin-associated autophagosome trafficking is purely
speculative, although it may provide an explanation that connects vimentin with
autophagosome-lysosome targeting. While Styers et al. (2004) did observe a
decrease

in

monodansylcadaverine

stained

organelles,

which

likely

represented autophagosomes in both vimentin-null cultures and AP-3-null
cultures, they did not examine if AP-3 and autophagosome transport were
affected by the filamentous status of vimentin in wild type cells.
In the current study, highly filamentous vimentin networks induced by
Bis-1 treatment resulted in the accumulation of GFP-LC3 punctate spots and an
increase in LC3-II expression that seemed to parallel increases in vimentin
filament immunostaining (compare Fig. 33 and 35). This accumulation
correlated with reduced autophagosome-lysosome fusion, a condition also
seen in U18666A-treated cultures (compare Fig. 36 to Fig. 14). This is in
agreement with previous studies that report that treatment with PKC inhibitors
Bis-1 or rottlerin result in autophagosome accumulation (Jiang et al., 2010).
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The observed correlation between highly complex filamentous vimentin

networks and autophagosome accumulation, suggests that an increase in
vimentin filaments results in the suppression of autophagosome transport to the
lysosome. To test this theory, I wanted to look closer at the interaction between
autophagosomes and vimentin filaments.

Confocal microscopy showed a

strong correlation between autophagosomes and vimentin filaments (Fig. 44A).
Bis-1- and U18666A-induced autophagosomes appear to be arranged along
vimentin filaments like ‘beads-on-a-string’ suggesting that autophagosomes are
physically associated with vimentin filament networks. Indeed, 3D modeling of
confocal images show autophagosomes sequestered within vimentin filament
networks suggesting that this association may impede autophagosome
transport to the lysosome (Fig. 44B). Therefore, highly filamentous vimentin
networks due to PKC inhibition may be the underlying mechanism behind
autophagosome accumulation.
To further test this theory, I wanted to determine if U18666A-induced
filamentous vimentin networks could be reversed by PKC activation. The
addition of the PKC activator TPA to U18666A-treated cultures resulted in a
time-dependent decrease in vimentin filament complexity (Fig. 37). Next, I
wanted to determine if PKC activation by treatment with TPA could faciliate the
clearance of lysosomal non-esterified cholesterol and autophagosomes.
Indeed, lysosomal non-esterified cholesterol was reduced in a time-dependent
manner with TPA treatment (Fig. 38). PKC activation also led to a shortening
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of autophagosome half-life (~3.9 h vs ~29 h) and to the clearance of U18666Ainduced autophagosomes within 8 h of TPA treatment (Fig. 39, 40 and 41).
Interestingly, autophagosome clearance occurred much earlier than nonesterified cholesterol clearance or vimentin filament network dissociation
(compare Fig. 37, Fig. 38 and Fig. 39). This difference in the kinetics of
autophagosome clearance and cholesterol egress suggests that vimentin
aggregation

may

affect

autophagosome

trafficking

and

non-esterified

cholesterol transport differently. One potential explanation could be that while
Rab9 may be entrapped within vimentin filaments preventing its role in nonesterified cholesterol transport, autophagosome trafficking may rely on the
dynamic assembly/disassembly of vimentin monomers. Restriction of vimentin
monomers to mature filaments may stall vimentin-mediated transport of
autophagosomes. To this effect, an analogous example would be the transport
of melanosomes within melanophores. Electron microscopy indicated that
melanosomes were encaged within vimentin filaments and that vimentin
underwent dynamic shape changes during melanosome movement and
correlated

to

increases

in

soluble

vimentin

(Chang

et

al.,

2009).

Autophagosomes may also rely on dynamic shape changes in vimentin
filaments for transport and this would require vimentin monomer cycling. In this
scenario, PKC activation would reestablish vimentin monomer cycling much
earlier than significant decreases in vimentin filament numbers. This may
explain the differential effects of TPA on the clearance of autophagosomes and
lysosomal non-esterfied cholesterol.
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Lastly, I wanted to determine if TPA treatment could theoretically reverse

the NPC phenotype within NPC fibroblasts. Treatment with 10 nM TPA for 24 h
had minimal effects on the vimentin network, but treatment with 40 nM for 24 h
successfully diminished vimentin filament staining suggestive of conversion of
vimentin to a more soluble form (Fig. 43). The same treatment protocol
revealed that TPA treatment successfully reduced non-esterfieid cholesterol
staining in a dose-dependent manner (Fig. 44). Then, under the same
treatment conditions, autophagosome clearance was monitored by LC3-II
Western blot analysis and revealed a decrease in LC3-II expression with 40 nM
TPA treatment for 24 h (Fig. 45). Notably, autophagosome clearance followed
similar kinetics as vimentin filament dissociation and clearance of lysosomal
non-esterified cholesterol. This differs from TPA studies performed in 1c1c7
cultures where autophagosome clearance occurred much earlier than
decreases in lysosomal non-esterified cholesterol content. This could be due to
cell specific responses to TPA. These studies support the finding that TPAmediated reversal of highly filamentous vimentin can effectively reverse the
NPC phenotype.
Both NPC fibroblasts and U18666A-treated cultures accumulate
sphingosine within late endosomes/lysosomes (te Vruchte et al., 2004).
Sphingosine happens to be a natural inhibitor of PKC (Bell et al., 1988). In the
current study I demonstrate that PKC inhibition results in a highly filamentous
vimentin network (Fig. 33). Therefore, this relationship raises the question:
does highly filamentous vimentin result from lysosomal non-esterified
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cholesterol/sterol

accumulation

or

does

lysosomal

non-esterified

cholesterol/sterol accumulation occur because of highly filamentous vimentin?
The most likely answer was proposed by Lloyd-Evans and Platt (2010) in their
description of the role of sphingosine in the propogation of NPC disease. They
proposed that NPC1 dysfunction leads to a primary accumulation of
sphingosine that causes a defect in lysosomal calcium. Lack of appropriate
calcium levels within the lysosome results in late endosome/lysosome
trafficking defects that subsequently generate secondary accumulations of
lipids including cholesterol. My studies partially agree with the Lloyd-Evans and
Platt’s theory. Indeed, sphingosine levels are considerably raised in brain, liver,
and spleen extracts of NPC mice (te Vruchte et al., 2004). Furthermore,
sphingosine accumulates within 10 min of U18666A treatment and is followed
by accumulation of cholesterol, sphingomyelin, and glycosphingolipids at 8 h
(Lloyd-Evans et al., 2008). NPC proteins may perform a role in sphingolipid
recycling

and

NPC

protein

dysfunction

would

result

in

sphingosine

accumulation (Malathi et al., 2004). While I can agree with the notion that
sphingosine accumulation is an early event in NPC, I propose that its inhibitory
effect on PKC results in highly filamentous vimentin, and it is this event that
leads to trafficking alterations.
Figure 45 depicts my model for a mechanistic explanation of the NPC
phenotype. NPC1 dysfunction results in the accumulation of lysosomal
sphingosine. Sphingosine inhibits PKC activity resulting in hypophosphorylation
of vimentin creating a highly filamentous vimentin network. Rab9 is restricted
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within the vimentin network preventing the egress of cholesterol, sphingomyelin
and glycosphingolipids from late endosomes/lysosomes resulting in nonesterified cholesterol/sterol accumulation. Autophagosomes are also restricted
within the filamentous vimentin network suppressing delivery to the lysosome
for degradation. This creates autophagic stress ultimately resulting in
neurodegeneration.

	
  
Figure 45: A mechanistic model for the propagation of the NPC
phenotype. Inhibition of NPC1 leads to the accumulation of sphingosine, which
inhibits PKC activity. PKC inhibition prevents the phosphorylation of vimentin,
which results in an increase in vimentin filament number. The highly
filamentous vimentin network entraps Rab9 inhibiting the egress of nonesterified cholesterol from the late endosome. This results in non-esterified
cholesterol accumulation within the late endosome/lysosome. At the same time,
autophagy is induced. Autophagosomes are sequestered within the highly
filamentous vimentin network preventing efficient delivery to the lysosome. This
results in autophagosome accumulation and autophagic stress.
Neurodegeneration results from either autophagic stress alone or in
combination with complications due to cholesterol accumulation within late
endosomes/lysosomes.
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In this body of work, I demonstrate a mechanistic explanation for the
accumulation of autophagosomes as part of the NPC phenotype. In summary,
vimentin filaments increased in number and complexity within U18666A treated
1c1c7 cultures, NPC fibroblasts and cultures treated with the PKC inhibitor Bis1. PKC inhibition led to accumulations in lysosomal non-esterified cholesterol
and autophagosomes that paralleled increasing vimentin filament number.
Autophagosomes appeared to be physically sequestered within vimentin
filament networks. Conversely, vimentin filament number could be decreased
by PKC activation. Treatment with the PKC activator TPA led to clearance of
autophagosomes and lysosomal non-esterified cholesterol in both U18666Atreated 1c1c7 cultures and in NPC fibroblasts. The significance of elucidating
the mechanism that leads to autophagosome accumulation and ultimately
autophagic stress in NPC disease will allow the development of targeted
therapeutics to correct the defect. For instance, the use of PKC activators may
be an applicable therapeutic for preventing the devasting neurodegenerative
symptoms of NPC. Future studies should be conducted to determine if the
same mechanism governs other LSDs that exhibit accumulations of lysosomal
non-esterified cholesterol/sterols and autophagosomes.
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CHAPTER 4

4.1 CONCLUSION
The molecular mechanism responsible for the strong correlation
between late endosomal/lysosomal non-esterified cholesterol accumulation and
autophagosome accumulation was examined within NPC fibroblasts and in
response to CAD treatment of the murine hepatoma cell line 1c1c7. The effects
of CAD treatment were both concentration- and time-dependent. CAD
treatment led to concurrent accumulations in lysosomal non-esterified
cholesterol and autophagosomes and ‘washout’ of the drug led to parallel
clearance. Immunohistochemical analysis revealed autophagosome and
lysosome colocalization was minimal, suggesting a defect in autophagosomelysosome fusion. Yet, autophagic ‘flux assays’ reveal CAD treatment results in
increased autophagosome synthesis and these autophagosomes continue to
undergo clearance by lysosomal degradation. Funtional assays revealed that
long-lived protein turn-over through the autophagic pathway was still functional
in U18666A-treated cultures, but occured at rates similar to non-treated
cultures.

However, the half-life of CAD-induced autophagosomes was

approximately 10-fold longer than that of autophagosomes induced by two
other common inducers of autophagy. Following leucine-starvation, nonesterifed cholesterol accumulations remained the same, but autophagosome
fusion and clearance were greatly enhanced (half-life ~2.6 h). This suggests
that non-esterified cholesterol accumulation does not impair autophagosomelysosome fusion. Taken together, these studies suggest that autophagosome
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accumulation is due to the inability of autophagosome degradation to keep
pace with autophagosome synthesis.
The ability of the leucine-starvation protocol to enhance U18666Ainduced autophagosome-lysosome fusion and decreased LC3-II content
suggested that the mTOR-signaling pathway might mediate this effect. Futher
analyses revealed mTOR is active during U18666A-treatment, but is inhibited
when shifted to leucine-starvation medium. The addition of rapamycin to
U18666A-treated cultures effectively inhibited mTOR activity, but did not reduce
LC3-II content. Further studies revealed that inhibition of mTOR by rapamycintreatment did not enhance autophagosome-lysosome fusion. Therefore, the
mTOR pathway is not involved in leucine starvation induced clearance of
U18666A-induced autophagosomes.
Additional studies focused on the ability of U18666A to induce
alterations in the three main cytoskeleton networks: MT, actin and IF.
Cytoskeletal networks mediate many intracellular trafficking events, including
autophagosome movement toward the lysosome for degradation. U18666Atreatment resulted in alterations in the IF vimentin and F-actin, but not in MT. Factin was disrupted in response to U18666A-treatment, but repolymerized
when cultures were shifted to leucine-starvation medium. Further studies
revealed that repolymerization of F-actin did not mediate enhanced
autophagosome-lysosome fusion. U18666A-treatment caused vimentin staining
patterns that appeared more filamentous than in control cultures, but similar to
staining patterns observed in NPC fibroblasts. From this observation, the
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relationship between filamentous vimentin networks and accumulations of nonesterified cholesterol and autophagosomes were further studied.
Vimentin filament assembly is mediated by its phosphorylation status,
which is determined by the activity of PKC. The PKC inhibitor Bis-1 resulted in
highly filamentous vimentin staining, accumulation of non-esterified cholesterol,
and autophagosome accumulation in 1c1c7 cultures. Bis-1 treatment also
exhibited a decrease in autophagosome-lysosome colocalization similar to that
observed in U18666A-treated cultures. For the first time, confocal microscopy
revealed that U18666A-induced autophagosomes corresponded with vimentin
filaments and appeared to be sequestered within the highly filamentous
vimentin network. Alternatively, the subsequent addition of the broad PKC
activator TPA to U18666A-treated cultures effectively reduced vimentin filament
staining, non-esterified cholesterol accumulation, and led to autophagosome
clearance. Treatment of patient derived NPC fibroblasts with TPA also resulted
in a decrease in vimentin filament staining, non-esterified cholesterol
accumulation, and a reduction in LC3-II expression. Taken together, these
studies suggest a cause-and-effect relationship between highly filamentous
vimentin networks and accumulations of lysosomal non-esterified cholesterol
and autophagosomes.
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Accumulations of autophagosomes and non-esterified cholesterol are
observed in several cell lines derived from lysosomal storage diseases,
including

Niemann

Pick

Type

C

(NPC).

The

relationship

between

autophagosome accumulation and lysosomal non-esterified cholesterol is
unclear. Exposure of murine hepatoma 1c1c7 cultures to the cationic
amphiphilic drugs (CADs) U18666A, imipramine and clozapine caused
lysosomal non-esterified cholesterol and autophagosome accumulation.
Measurement of LC3-II conversion in the presence of lysosomal inhibitors
bafilomycin
colocalization

A1
of

and

NH4Cl,

GFP-LC3

degradation
and

LAMP1

of

long-lived

indicated

an

proteins,
increase

and
in

autophagosome synthesis without compensatory increase in clearance.
Autophagosome synthesis was blocked using 3-MA to monitor pre-existing
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autophagosome

degradation.

Autophagosomes

generated

by

leucine-

starvation or treatment with rapamycin, U18666A or clozapine had an
estimated half-life of ~0.7, 2.5, 29 and 26 h, respectively. Shifting U18666Atreated cultures to leucine-starvation media enhanced autophagosome
clearance (half-life ~2.6 h), without effecting non-esterified cholesterol content
suggesting lysosomal non-esterified cholesterol content did not inhibit
autophagosome-lysosome fusion. Therefore, U18666A-mediated effects on
trafficking were investigated.
Fluorescent microscopy analysis revealed U18666A treatment affected
F-actin and vimentin, but not microtubules. Rhodamine-phalloidin staining
indicated U18666A induced F-actin depolymerization. Actin repolymerized
when cultures were shifted to leucine-starvation medium. However, this effect
did not mediate enhanced autophagosome clearance. Immunofluorescence
staining patterns of vimentin filaments increased in number and complexity in
U18666A-treated normal human fibroblasts similar to NPC fibroblasts. Inhibition
of PKC by bisindolylmaleimide 1 (Bis-1) treatment of 1c1c7 cultures favored the
formation of filamentous vimentin, accumulation of non-esterified cholesterol
and autophagosomes, and decreased GFP-LC3 and LAMP1 colocalization.
Confocal microscopy revealed that autophagosomes associated with vimentin
filaments following U18666A and Bis-1 treatment, but not with leucine
starvation. The addition of PKC activator 12-O-tetradecanoylphorbol-13-acetate
(TPA) to U18666AA-treated cultures resulted in vimentin filament dissociation
and decreases in 1c1c7 and NPC fibroblast culture cholesterol content.
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Analyses of GFP-LC3 indicated enhanced autophagosome clearance (half-life
reduced to ~3.6 h) in 1c1c7 cultures. Western blot analysis showed that LC3-II
decreased in NPC fibroblasts within 24 h of TPA-treatment. The cumulative
data suggest that autophagosome accumulation in NPC fibroblasts or in
response to CAD-treatment is due to increased autophagosome synthesis
paired with inefficient degradation due to sequestration of autophagosomes
within vimentin filament networks.
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